EVIO (EVIO) 10-Q 9 Sep 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Jun. 30, 2020	Sep. 04, 2020
Cover [Abstract]
Entity Registrant Name	EVIO, INC.
Entity Central Index Key	0000715788
Document Type	10-Q
Document Period End Date	Jun. 30, 2020
Amendment Flag	false
Current Fiscal Year End Date	--09-30
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		89,142,473
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2020	Sep. 30, 2019
Current assets:
Cash and cash equivalents	$ 71,396	$ 110,325
Accounts receivable, net	110,786	133,022
Prepaid expenses	105,039	190,460
Other current assets	44,766	9,689
Note receivable, current portion	538,904	538,904
Total current assets	870,891	982,400
Right of use assets	1,832,856	2,543,976
Capital assets, net	1,116,734	1,383,828
Land	212,550	212,550
Property and equipment, net	2,643,460	3,080,426
Security deposits	176,650	178,918
Prepaid expenses, net		4,061
Total assets	6,853,141	8,386,159
Current liabilities:
Accounts payable and accrued liabilities	4,443,243	3,811,237
Client deposits	42,022	108,418
Interest payable	1,693,136	1,387,642
Capital lease obligation, current	902,894	957,673
Derivative liability	2,134,395	2,545,735
Convertible notes payable, net of discounts	3,721,712	3,695,484
Loans payable, net of discounts, current	788,006	762,476
Total current liabilities	13,725,408	13,268,665
Convertible debentures, net of loan discounts	3,694,043	1,734,890
Lease liabilities	1,886,722	2,594,726
Capital lease obligation, net	121,729	381,786
Loans payable, net	702,578	657,603
Loans payable, related party, net	1,417,793	1,560,849
Total liabilities	21,548,273	20,198,519
Commitments and contingencies
Stockholders' Equity:
Common stock, $0.0001 par value. 1,000,000,000 authorized; 94,217,473 and 29,314,419 shares issued and outstanding at June 30, 2020 and September 30, 2019, respectively	9,422	2,931
Stock subscriptions receivable
Additional paid-in capital	30,001,524	26,498,076
Retained earnings (accumulated deficit)	(44,391,942)	(37,775,183)
Accumulated other comprehensive income	(328,036)	(353,090)
Total stockholders' equity	(14,708,448)	(11,626,682)
Noncontrolling interest	13,317	(185,678)
Total equity	(14,695,131)	(11,812,360)
Total liabilities and equity	6,853,142	8,386,159
Series B Convertible Preferred Stock [Member]
Stockholders' Equity:
Preferred stock	500	500
Total stockholders' equity	500	500
Total equity	500	500
Series C Convertible Preferred Stock [Member]
Stockholders' Equity:
Preferred stock	50	50
Total stockholders' equity	50	50
Total equity	50	50
Series D Convertible Preferred Stock [Member]
Stockholders' Equity:
Preferred stock	34	55
Total stockholders' equity	34	34
Total equity	$ 34	$ 34

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jun. 30, 2020	Sep. 30, 2019
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	94,217,473	29,314,419
Common stock, shares outstanding	94,217,473	29,314,419
Series B Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	5,000,000	5,000,000
Preferred stock, shares outstanding	5,000,000	5,000,000
Series C Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	500,000	500,000
Preferred stock, shares outstanding	500,000	500,000
Series D Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	349,500	349,500
Preferred stock, shares outstanding	349,500	349,500

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Revenues
Total revenues	$ 603,192	$ 1,101,310
Cost of revenue
Depreciation and amortization	289,594	289,523
Total cost of revenue	743,267	1,113,063
Gross margin	(140,075)	(11,753)
Operating expenses:
Selling, general and administrative	147,873	1,504,539
Depreciation and amortization	17,907	62,291
Total operating expenses	165,780	1,566,830
Income (loss) from operations	(305,855)	(1,578,583)
Other income (expense)
Interest income (expense), net	(960,485)	(592,089)
Other income (expense)	(359,805)	(178,549)
Gain (loss) on settlement of debt
Impairment charge
Gain (loss) on change in fair market value of derivative liabilities	224,783	981,421
Total other income (expense)	(1,095,507)	210,783
Income (loss) before income taxes	(1,401,362)	(1,367,800)
Provision for income taxes (benefit)		2,735
Net income (loss)	(1,401,362)	(1,370,535)
Net income (loss) attributable to noncontrolling interest	(51,954)	(49,257)
Net income (loss) attributable to EVIO, Inc. shareholders	$ (1,349,408)	$ (1,321,278)
Basic and diluted earnings (loss) per common share	$ (0.03)	$ (0.05)
Weighted-average number of common shares outstanding: Basic and diluted	49,561,707	25,366,021
Comprehensive loss:
Net income (loss)	$ (1,401,362)	$ (1,370,535)
Foreign currency translation adjustment	26,282	64,261
Comprehensive income (loss)	(1,375,080)	(1,306,274)
Testing Revenue [Member]
Revenues
Total revenues	603,192	1,098,310
Cost of revenue
Cost of revenue for services	455,947	823,540
Consulting Revenue [Member]
Revenues
Total revenues		3,000
Cost of revenue
Cost of revenue for services	$ (1,824)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		6 Months Ended	9 Months Ended		12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Mar. 31, 2020	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2019
Cash flows from operating activities of continuing operations:
Net income (loss)	$ (1,401,362)	$ (1,370,535)	$ (6,688,377)	$ (6,688,377)	$ (7,842,302)	$ (20,669,033)
Adjustments to reconcile net loss to cash used in operating activities:
Amortization of debt discount				2,875,551	2,241,279
Common stock issued in exchange for fees and services				333,830	342,910
Default penalties and other covenant adjustments on convertible debentures				62,500
Deferred taxes
Depreciation and amortization				819,099	1,080,100
Impairment of goodwill and long lived assets				375,614
Loss on disposal of assets				2,979	64,095
Loss on settlement of accounts payable
Loss on settlement of debt				10,000
Provision for doubtful accounts				25,873	49,835
Provision for excess or obsolete inventory
Stock based compensation				903,683	576,124
Unrealized (gain) loss on derivative liability	(224,783)	(981,421)		(450,580)	(424,774)
Changes in operating assets and liabilities:
Accounts receivable				(7,944)	(144,052)
Prepaid expenses				89,483	(74,605)
Other current assets				(35,115)	89,842
Security deposits				1,775	(35,646)
Operating lease right of use assets				3,116	49,541
Other assets
Accounts payable and accrued liabilities				471,812	1,281,150
Customer deposits and deferred revenues				(66,397)	(206,113)
Deposits, related party
Income taxes payable
Interest payable				515,321	595,752
Net cash provided by (used in) operating activities				(757,777)	(2,356,864)
Cash flows from investing activities:
Cash consideration for acquisition of business
Notes receivable					761,096
Purchase of fixed assets				(39,206)	(853,644)
Purchase of intangible assets
Net cash provided by (used in) financing activities				(39,206)	(92,548)
Cash flows from financing activities:
Proceeds from issuance of preferred stock, net of issuance costs
Proceeds from issuance of common stock, net of issuance costs					592,000
Proceeds from exercise of common stock purchase warrants, net of issuance costs
Proceeds from issuance of convertible debentures					374,000
Proceeds from issuance of convertible notes, net of issuance costs				1,055,102	1,078,732
Proceeds from loans payable					2,718
Proceeds from related party advances				80,431	144,193
Repayments of capital leases				(294,727)	274,553
Repayments of convertible debentures
Repayments of loans payable				(34,920)	(30,476)
Repayments of related party loans payable				(71,063)	(11,906)
Net cash provided by (used in) financing activities				734,823	2,423,814
Effect of exchange rates on cash and cash equivalents				23,232	4,927
Net increase (decrease) in cash and cash equivalents				(38,928)	(20,671)
Cash and cash equivalents at beginning of period			110,325	110,325	81,735	81,735
Cash and cash equivalents at end of period	71,397	61,064		71,397	61,064	110,325
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Supplemental disclosure of non-cash investing and financing activities:
Conversion of convertible note and accrued interest into common stock				1,828,842	708,089
Reclassification of derivative liability to additional paid in capital		$ 1,459,658
Settlement of account payable for common stock				6,000
Common stock issued for settlement of note payable					15,000
Common stock issued for settlement of related party note payable
Common stock issued for subscription receivable
Conversion of Series D Preferred stock to common stock					364,462
Debt discount recorded on convertible notes and debentures payable upon initial measurement of derivative liability				39,241	846,985
Debt discounts recorded for beneficial conversion features on convertible debentures and notes payable				260,083
Debt discounts recorded for original issue discounts on convertible debentures
Vehicles financed through notes payable				105,424
Equipment financed through capital leases					322,383
Issuance of convertible notes payable and other obligations in connection with the acquisition of a business
Sale and assumption of note payable and accrued interest					$ 556,658

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Series B Convertible Preferred Stock [Member]	Series C Convertible Preferred Stock [Member]	Series D Convertible Preferred Stock [Member]	Common Stock [Member]	Stock Subscriptions Receivable [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income [Member]	Stockholders' Equity [Member]	Noncontrolling Interest [Member]	Total
Beginning Balance at Sep. 30, 2018	$ 500	$ 50	$ 55	$ 2,326		$ 21,495,621	$ (19,226,462)	$ (263,985)	$ 2,008,105	$ 1,934,634	$ 3,942,739
Beginning Balance, shares at Sep. 30, 2018	5,000,000	5,000,000	552,500	23,255,411
Net income (loss)											(7,842,302)
Reclassification of derivative liability to additional paid-in capital
Ending Balance at Jun. 30, 2019	$ 500	$ 50	$ 55	$ 1,971		18,073,657	(13,458,754)	(317,132)	4,300,347	2,250,322	6,550,669
Ending Balance, shares at Jun. 30, 2019	5,000,000	5,000,000	552,500	19,719,903
Beginning Balance at Sep. 30, 2018	$ 500	$ 50	$ 55	$ 2,326		21,495,621	(19,226,462)	(263,985)	2,008,105	1,934,634	3,942,739
Beginning Balance, shares at Sep. 30, 2018	5,000,000	5,000,000	552,500	23,255,411
Net income (loss)							(18,548,721)		(18,548,721)	(2,120,312)	(20,669,033)
Change in foreign currency translation								(89,105)	(89,105)		(89,105)
Issuance of common stock in connection with the conversion of Series D preferred stock			$ (21)	$ 53		(32)
Issuance of common stock in connection with the conversion of Series D preferred stock, shares			(213,000)	532,500
Issuance of common stock in connection with sales made under private offerings				$ 141		591,859			592,000		592,000
Issuance of common stock in connection with sales made under private offerings, shares				1,415,000
Issuance of common stock in connection with stock subscriptions received under private offerings
Issuance of common stock in connection with stock subscriptions received under private offerings, shares
Issuance of common stock in connection with the exercise of common stock purchase warrants
Issuance of common stock in connection with the exercise of common stock purchase warrants, shares
Issuance of common stock as compensation to employees, officers and/or directors				$ 29		397,691			397,720		397,720
Issuance of common stock as compensation to employees, officers and/or directors, shares				287,500
Issuance of common stock in exchange for consulting, professional and other services provided				$ 104		331,047			331,151		331,151
Issuance of common stock in exchange for consulting, professional and other services provided, shares				1,038,017
Issuance of common stock in connection with the conversion of loans payable				$ 205		686,995			687,200		687,200
Issuance of common stock in connection with the conversion of loans payable, shares				2,054,887
Issuance of common stock in connection with the conversion of debentures				$ 67		387,933			388,000		388,000
Issuance of common stock in connection with the conversion of debentures, shares				669,362
Issuance of common stock in connection with the conversion of interest payable				$ 1		25,109			25,110		25,110
Issuance of common stock in connection with the conversion of interest payable, shares				10,163
Issuance of common stock in satisfaction of debt issuances costs
Issuance of common stock in satisfaction of debt issuances costs, shares
Issuance of common stock in connection with the settlement of accounts payable				$ 3		14,997			15,000		15,000
Issuance of common stock in connection with the settlement of accounts payable, shares				31,579
Issuance of common stock in connection with the settlement of notes payable
Issuance of common stock in connection with the settlement of notes payable, shares
Issuance of common stock in connection with the conversion of related party notes payable
Issuance of common stock in connection with the conversion of related party notes payable, shares
Issuance of common stock purchase warrants in satisfaction of debt issuances costs				$ 2		11,758			11,760		11,760
Issuance of common stock purchase warrants in satisfaction of debt issuances costs, shares				20,000
Reclassification of derivative liability to additional paid-in capital
Recognition of beneficial conversion features related to convertible debt instruments						1,844,834			1,844,834		1,844,834
Stock based compensation related to employee stock options						710,264			710,264		710,264
Acquisition of equity interests in subsidiaries
Ending Balance at Sep. 30, 2019	$ 500	$ 50	$ 34	$ 2,931		26,498,076	(37,775,183)	(353,090)	(11,626,682)	(185,678)	(11,812,360)
Ending Balance, shares at Sep. 30, 2019	5,000,000	5,000,000	339,500	29,314,419
Beginning Balance at Mar. 31, 2019	$ 500	$ 50	$ 55	$ 1,606		12,925,709	(10,258,765)		2,669,155	545,328	3,214,483
Beginning Balance, shares at Mar. 31, 2019	5,000,000	5,000,000	552,500	16,068,505
Net income (loss)							(3,199,989)		(3,199,989)	(257,101)	(1,370,535)
Change in foreign currency translation								(317,132)	(317,132)		64,261
Issuance of common stock in connection with the conversion of Series D preferred stock
Issuance of common stock in connection with the conversion of Series D preferred stock, shares
Issuance of common stock in connection with sales made under private offerings				$ 129		1,533,372			1,533,501		1,533,501
Issuance of common stock in connection with sales made under private offerings, shares				1,291,392
Issuance of common stock in connection with the exercise of common stock purchase warrants				$ 1		7,998			7,999		7,999
Issuance of common stock in connection with the exercise of common stock purchase warrants, shares				13,333
Issuance of common stock as compensation to employees, officers and/or directors				$ 14		272,548			272,562		272,562
Issuance of common stock as compensation to employees, officers and/or directors, shares				140,000
Issuance of common stock in exchange for consulting, professional and other services provided				$ 2		10,805			10,807		10,807
Issuance of common stock in exchange for consulting, professional and other services provided, shares				15,000
Issuance of common stock in connection with the conversion of loans payable				$ 212		1,493,573			1,493,785		1,493,785
Issuance of common stock in connection with the conversion of loans payable, shares				2,121,233
Issuance of common stock in connection with the conversion of debentures
Issuance of common stock in connection with the conversion of debentures, shares
Issuance of common stock in connection with the conversion of interest payable				$ 7		48,096			48,103		48,103
Issuance of common stock in connection with the conversion of interest payable, shares				70,440
Issuance of common stock in satisfaction of debt issuances costs
Issuance of common stock in satisfaction of debt issuances costs, shares
Issuance of common stock in connection with the settlement of accounts payable
Issuance of common stock in connection with the settlement of accounts payable, shares
Issuance of common stock in connection with the settlement of notes payable
Issuance of common stock in connection with the settlement of notes payable, shares
Issuance of common stock in connection with the conversion of related party notes payable
Issuance of common stock in connection with the conversion of related party notes payable, shares
Common stock options issued under employee equity incentive plan						321,898			321,898		321,898
Reclassification of derivative liability to additional paid-in capital						1,459,658			1,459,658		1,459,658
Recognition of beneficial conversion features related to convertible debt instruments
Acquisition of equity interests in subsidiaries										1,962,095	1,962,095
Ending Balance at Jun. 30, 2019	$ 500	$ 50	$ 55	$ 1,971		18,073,657	(13,458,754)	(317,132)	4,300,347	2,250,322	6,550,669
Ending Balance, shares at Jun. 30, 2019	5,000,000	5,000,000	552,500	19,719,903
Beginning Balance at Sep. 30, 2019	$ 500	$ 50	$ 34	$ 2,931		26,498,076	(37,775,183)	(353,090)	(11,626,682)	(185,678)	(11,812,360)
Beginning Balance, shares at Sep. 30, 2019	5,000,000	5,000,000	339,500	29,314,419
Net income (loss)							(6,616,759)		(6,616,759)	(71,618)	(6,688,377)
Change in foreign currency translation								25,054	25,054		25,054
Issuance of common stock in connection with the conversion of Series D preferred stock
Issuance of common stock in connection with the conversion of Series D preferred stock, shares
Issuance of common stock in connection with sales made under private offerings
Issuance of common stock in connection with sales made under private offerings, shares
Issuance of common stock in connection with stock subscriptions received under private offerings
Issuance of common stock in connection with stock subscriptions received under private offerings, shares
Issuance of common stock in connection with the exercise of common stock purchase warrants
Issuance of common stock in connection with the exercise of common stock purchase warrants, shares
Issuance of common stock as compensation to employees, officers and/or directors				$ 745		742,367			743,112		743,112
Issuance of common stock as compensation to employees, officers and/or directors, shares				7,453,538
Issuance of common stock in exchange for consulting, professional and other services provided				$ 578		333,252			333,830		333,830
Issuance of common stock in exchange for consulting, professional and other services provided, shares				5,775,670
Issuance of common stock in satisfaction of debt default penalties				$ 229		62,271			62,500		62,500
Issuance of common stock in satisfaction of debt default penalties, shares				2,285,449
Issuance of common stock in connection with the conversion of loans payable
Issuance of common stock in connection with the conversion of loans payable, shares
Issuance of common stock in connection with the conversion of debentures				$ 3,961		$ 1,615,424			$ 1,619,385		$ 1,619,385
Issuance of common stock in connection with the conversion of debentures, shares				39,606,438
Issuance of common stock in connection with the conversion of interest payable				$ 461		208,996			209,457		209,457
Issuance of common stock in connection with the conversion of interest payable, shares				4,610,365
Issuance of common stock in connection with the settlement of accounts payable				$ 3		5,997			6,000		6,000
Issuance of common stock in connection with the settlement of accounts payable, shares				26,666
Issuance of common stock in connection with the settlement of a legal matter				$ 14		9,986			10,000		10,000
Issuance of common stock in connection with the settlement of a legal matter, shares				144,928
Issuance of common stock in connection with the settlement of notes payable
Issuance of common stock in connection with the settlement of notes payable, shares
Issuance of common stock in connection with the conversion of related party notes payable
Issuance of common stock in connection with the conversion of related party notes payable, shares
Issuance of common stock purchase warrants in satisfaction of debt issuances costs
Issuance of common stock purchase warrants in satisfaction of debt issuances costs, shares
Reclassification of derivative liability to additional paid-in capital
Recognition of beneficial conversion features related to convertible debt instruments						260,083			260,083		260,083
Stock based compensation related to employee stock options						160,571			160,571		160,571
Acquisition of equity interests in subsidiaries				$ 500		104,500			105,000	270,614	375,614
Acquisition of equity interests in subsidiaries, shares				5,000,000
Ending Balance at Mar. 31, 2020	$ 500	$ 50	$ 34	$ 9,422		30,001,523	(44,391,942)	(328,036)	(14,708,449)	13,318	(14,695,131)
Ending Balance, shares at Mar. 31, 2020	5,000,000	500,000	339,500	94,217,473
Beginning Balance at Sep. 30, 2019	$ 500	$ 50	$ 34	$ 2,931		26,498,076	(37,775,183)	(353,090)	(11,626,682)	(185,678)	(11,812,360)
Beginning Balance, shares at Sep. 30, 2019	5,000,000	5,000,000	339,500	29,314,419
Net income (loss)											(6,688,377)
Reclassification of derivative liability to additional paid-in capital
Ending Balance at Jun. 30, 2020	$ 500	$ 50	$ 34	$ 9,422		30,001,523	(44,391,942)	(328,036)	(14,708,449)	13,318	(14,695,131)
Ending Balance, shares at Jun. 30, 2020	5,000,000	500,000	339,500	94,217,473
Beginning Balance at Mar. 31, 2020	$ 500	$ 50	$ 34	$ 9,422		30,001,523	(44,391,942)	(328,036)	(14,708,449)	13,318	(14,695,131)
Beginning Balance, shares at Mar. 31, 2020	5,000,000	500,000	339,500	94,217,473
Net income (loss)							(1,349,408)		(1,349,408)	(51,954)	(1,401,362)
Change in foreign currency translation								20,131	20,131		26,282
Issuance of common stock in connection with the conversion of Series D preferred stock
Issuance of common stock in connection with the conversion of Series D preferred stock, shares
Issuance of common stock in connection with sales made under private offerings
Issuance of common stock in connection with sales made under private offerings, shares
Issuance of common stock in connection with stock subscriptions received under private offerings
Issuance of common stock in connection with stock subscriptions received under private offerings, shares
Issuance of common stock in connection with the exercise of common stock purchase warrants
Issuance of common stock in connection with the exercise of common stock purchase warrants, shares
Issuance of common stock as compensation to employees, officers and/or directors
Issuance of common stock as compensation to employees, officers and/or directors, shares
Issuance of common stock in exchange for consulting, professional and other services provided				$ 50		4,950			5,000		5,000
Issuance of common stock in exchange for consulting, professional and other services provided, shares				500,000
Issuance of common stock in connection with the conversion of loans payable
Issuance of common stock in connection with the conversion of loans payable, shares
Issuance of common stock in connection with the conversion of debentures				$ 1,000		$ 99,000			$ 100,000		$ 100,000
Issuance of common stock in connection with the conversion of debentures, shares				10,000,000
Issuance of common stock in connection with the conversion of interest payable
Issuance of common stock in connection with the conversion of interest payable, shares
Issuance of common stock in satisfaction of debt issuances costs
Issuance of common stock in satisfaction of debt issuances costs, shares
Issuance of common stock in connection with the settlement of accounts payable
Issuance of common stock in connection with the settlement of accounts payable, shares
Issuance of common stock in connection with the settlement of a legal matter
Issuance of common stock in connection with the settlement of a legal matter, shares
Issuance of common stock in connection with the settlement of notes payable
Issuance of common stock in connection with the settlement of notes payable, shares
Issuance of common stock in connection with the conversion of related party notes payable
Issuance of common stock in connection with the conversion of related party notes payable, shares
Issuance of common stock purchase warrants in satisfaction of debt issuances costs
Issuance of common stock purchase warrants in satisfaction of debt issuances costs, shares
Reclassification of derivative liability to additional paid-in capital
Recognition of beneficial conversion features related to convertible debt instruments						84,763			84,763		84,763
Stock based compensation related to employee stock options						13,173			13,173		13,173
Acquisition of equity interests in subsidiaries				$ 500		104,500			105,000	270,614	375,614
Acquisition of equity interests in subsidiaries, shares				5,000,000
Ending Balance at Jun. 30, 2020	$ 500	$ 50	$ 34	$ 9,422		$ 30,001,523	$ (44,391,942)	$ (328,036)	$ (14,708,449)	$ 13,318	$ (14,695,131)
Ending Balance, shares at Jun. 30, 2020	5,000,000	500,000	339,500	94,217,473

Organization, Basis of Presenta

Organization, Basis of Presentation and Significant Accounting Policies	9 Months Ended
	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Basis of Presentation and Significant Accounting Policies	NOTE 1 – ORGANIZATION, BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES EVIO, Inc., a Colorado corporation and its subsidiaries provide analytical testing and advisory services to the emerging legalized cannabis industry. EVIO, Inc. was originally incorporated in the State of New York, December 12, 1977, under the name 3171 Holding Corporation. On February 22, 1979, the name was changed to Electronomic Industries Corp. and on February 23, 1983, the name was changed to Quantech Electronics Corp. The Company was reincorporated in the State of Colorado on December 15, 2003. On August 29, 2014, the Company completed a reverse merger with Signal Bay Research, Inc., a Nevada Corporation, and assumed its operations. In September 2014, the Company changed its name from Quantech Electronics Corp. to Signal Bay, Inc. then to EVIO, INC. in August 2018. The Company has selected September 30 as its fiscal year-end. The Company is domiciled in the State of Colorado, and its corporate headquarters are located in Henderson, Nevada. As a part of and prior to the consummation of the reverse merger, William Waldrop and Lori Glauser, principals of Signal Bay Research, Inc., purchased 80% of the issued and outstanding common stock from WB Partners. The merger between the Company and Signal Bay Research was finalized and closed contemporaneously with the share purchase. As part of this share purchase, Mr. Waldrop and Ms. Glauser became the officers and directors of the Company. Immediately after the reverse, WB Partners owned less than 5% of the common stock. The company filed a Form 10-12G on November 25, 2014, and was determined to be a shell company by the SEC as per the Form 10-12G/A which went effective on January 24, 2015. On January 29, 2015, the company filed an 8-K stating it entered into a material agreement and was no longer a shell company. After the reverse merger, Signal Bay Research, Inc. continues to operate as a wholly-owned subsidiary providing compliance, research, and advisory services for Signal Bay, Inc. Signal Bay Services was formed on January 25, 2015, as the management services division of EVIO. On September 17, 2015, EVIO entered into a share exchange agreement with CR Labs, Inc., an Oregon Corporation, pursuant to which the Company acquired 80% of the outstanding common stock of CR Labs, Inc. EVIO Inc. was formed on April 4, 2016, to become the holding company for all laboratory operations. EVIO Labs Eugene was formed on May 23, 2016, as a wholly-owned subsidiary of EVIO Inc. Subsequently, on May 24, 2016, EVIO Labs Eugene acquired all of the assets of Oregon Analytical Services, LLC, inclusive of client lists, equipment, trade names, and personnel. On June 1, 2016, EVIO Inc. entered into a share purchase agreement to purchase 80% of the outstanding common stock of Smith Scientific Industries, Inc. d/b/a Kenevir Research in Medford, OR. On October 19, 2016, the Company entered into a Membership Interest Purchase Agreement to purchase 100% of the ownership of GreenHaus Analytical Labs, LLC. On October 26, 2016, the Company entered into an Asset Purchase Agreement with Green Style Consulting, LLC which was closed on November 1, 2016. The Company entered into a Membership Interest Purchase Agreement with Viridis Analytics MA, LLC which was closed on August 1, 2018. On December 29, 2018, the Company entered into a Membership Purchase Agreement to purchase 60% of the outstanding shares of C3 Labs, LLC which closed On January 1, 2019. On June 27, 2018, Greenhaus Analytical Labs LLC, a wholly-owned subsidiary of EVIO, Inc. entered into a Purchase and Sale Agreement with Michael G. Myers for the property located at 14775 SW 74 th On June 27, 2018, Greenhaus Analytical Labs, LLC, a wholly-owned subsidiary of EVIO, Inc., entered into an Asset Purchase Agreement with MRX Labs LLC which closed on July 5, 2019. On April 29, 2018, the Company entered into an Asset Purchase Agreement with Leaf Detective, LLC which was closed on the same date. On May 2, 2018, the Company entered into a Stock Purchase Agreement with Keystone, Labs, Inc. to purchase 50% of the outstanding shares of Keystone Labs which was closed on the same date. On May 29, 2020, the Company entered into a Membership Interest Purchase Agreement with Green Analytics to sell 100% of Viridis Analytics, MA, subject to permission of the Massachusetts Cannabis Control Commission. Management’s Representation of Interim Financial Statements The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission and should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s most recent Annual Financial Statements filed with the SEC on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim period presented have been reflected herein. The results of operations for the interim period are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosures contained in the audited consolidated financial statements for the most recent fiscal period, as reported in the Form 10-K, have been omitted. Basis of Presentation The consolidated financial statements of the Company have been prepared in accordance with GAAP and are expressed in United States dollars. For the three months ended June 30, 2020, and 2019, and the year ended September 30, 2019, the consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. The subsidiaries of EVIO, Inc. are as follows: Trade Name (dba) Company Name State of Ownership % Acquisition Month EVIO Labs Medford Smith Scientific Industries, LLC Oregon 80 % June 2016 EVIO Labs Portland Greenhaus Analytical Labs Oregon 100 % October 2016 EVIO Labs MA Viridis Analytics Massachusetts 100 % August 2017 EVIO Labs Berkeley C3 Labs, LLC California 90 % January 2018 Keystone Labs Keystone Labs, Inc. Ontario, Canada 50 % May 2018 Revenue Recognition The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers. The core principle of the new revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied to achieve that core principle: ● Step 1: Identify the contract with the customer ● Step 2: Identify the performance obligations in the contract ● Step 3: Determine the transaction price ● Step 4: Allocate the transaction price to the performance obligations in the contract ● Step 5: Recognize revenue when the company satisfies a performance obligation The Company generates revenue from consulting services, licensing agreements, and testing of cannabis and hemp products for medicinal and adult-use consumption. The Company accounts for a contract after it has been approved by all parties to the arrangement, the rights of the parties are identified, payment terms are identified, the contract has commercial substance, and collectability of consideration is probable. The Company evaluates the services promised in each contract at inception to determine whether the contract should be accounted for as having one or more performance obligations. The Company’s services included in its contracts are distinct from one another. The Company determines the transaction price for each contract based on the consideration it expects to receive for the distinct services being provided under the contract. The Company recognizes revenue as performance obligations are satisfied and the customer obtains control of the services provided. In determining when performance obligations are satisfied, the Company considers factors such as contract terms, payment terms, and whether there is an alternative future use of the service. The Company recognizes revenue from testing services upon delivery of its testing results to the client. Customer orders for testing services are generally completed within two weeks of receiving the order. Consulting engagements may vary in length and scope, but will generally include the review and/or preparation of regulatory filings, business plans, and financial models, operating plans, and technology support to customers within the same industry. Revenue from consulting services is recognized upon completion of deliverables as outlined in the consulting agreement. The Company recognizes revenue from the right of use license agreements upon transfer of control of the functional intellectual property. In certain licensing agreements, the Company may receive royalty revenues based upon performance metrics which are recognized as earned over time. Stock-Based Compensation In accordance with ASC No. 718, Compensation-Stock Compensation (“ASC 718”), the Company measures the cost of stock-based compensation arrangements based on the grant date fair value and recognizes the cost in the financial statements over the period during which employees are required to provide services. Stock-based compensation arrangements may include stock options, restricted stock plans, performance-based awards, stock appreciation rights, and employee stock purchase plans. The Company utilizes the Black Scholes option pricing model, which was developed for use in estimating the fair value of options. Option pricing models require the input of highly complex and subjective variables including the expected life of options granted and the expected volatility of the Company’s stock price over a period equal to or greater than the expected life of the options. Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are recorded at their original invoice amounts. We regularly review collectability and establish an allowance for uncollectible amounts as necessary based on our experience with historical collectability. Management recognized an allowance for uncollectible amounts, of $170,666 and $215,593 for the periods ended June 30, 2020, and September 30, 2019, respectively. Foreign Currency Translation The functional currency of the Company’s subsidiary in Canada is the Canadian Dollar. The subsidiary’s assets and liabilities have been translated to U.S. Dollars using the exchange rates in effect at the balance sheet dates. Statements of operations amounts have been translated using the average exchange rate for each period. Resulting gains or losses from translating foreign currency financial statements are recorded as other comprehensive income (loss). Fair Value of Financial Instruments The Company has adopted the guidance under ASC Topic 820 for financial instruments measured on fair value on a recurring basis. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Net Income (Loss) Per Share Basic loss per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. There were 94,142,473 and 26,160,911 potentially dilutive common shares outstanding as of June 30, 2020 and 2019, respectively. Because of the net losses incurred during the three months ended June 30, 2020, and 2019, the impacts of dilutive instruments would have been anti-dilutive for the period presented and have been excluded from the diluted loss per share calculations. Recently Issued Accounting Pronouncements In January 2017, the FASB issued ASU 2017-04, “ Intangibles—Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment”. In January 2017, the FASB issued ASU 2017-01, “ Business Combinations (Topic 805): Clarifying the Definition of a Business, In June 2018, the FASB issued ASU 2018-07, Compensation-Stock Compensation (Topic 718) Compensation-Stock Compensation Revenue from Contracts with Customers In August 2018, the SEC issued Final Rule Release No. 33-10532, Disclosure Update, and Simplification. Under the final rule Company’s must now analyze changes in stockholders’ equity in the form of a reconciliation, for the current and comparative year-to-date, with subtotals for each interim period. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our financial statements upon adoption.

Going Concern

Going Concern	9 Months Ended
	Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 2 – Going concern The Company’s financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company has negative working capital, recurring losses, and does not have an established source of revenues sufficient to cover its operating costs. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plan described in the preceding paragraph and eventually attain profitable operations. The accompanying financial statements do not include any adjustments that may be necessary if the Company is unable to continue as a going concern. In the coming year, the Company’s foreseeable cash requirements will relate to the continual development of the operations of its business, maintaining its good standing and making the requisite filings with the Securities and Exchange Commission, and the payment of expenses associated with operations and business developments. The Company may experience a cash shortfall and be required to raise additional capital. Historically, it has mostly relied upon convertible debentures, convertible promissory notes, internally generated funds such as shareholder loans and advances to finance its operations and growth. Management may raise additional capital by retaining net earnings or through future public or private offerings of the Company’s stock or loans from private investors, although there can be no assurance that it will be able to obtain such financing. Additionally, due to the onset of COVID-19 obtaining financing may be more difficult to obtain currently compared to historic levels. The Company’s failure to do so could have a material and adverse effect upon it and its shareholders.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Jun. 30, 2020
Investments, All Other Investments [Abstract]
Fair Value of Financial Instruments	Note 3 – FAIR VALUE OF FINANCIAL INSTRUMENTS The Company has adopted the guidance under ASC Topic 820 for financial instruments measured on a fair value on a recurring basis. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC Topic 820 establishes a fair value hierarchy, giving the highest priority to quoted prices in active markets and the lowest priority to unobservable data and requires disclosures for assets and liabilities measured at fair value based on their level in the hierarchy. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows: ● Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. ● Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. ● Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist principally cash, accounts payable, and accrued liabilities. The carrying values of these financial instruments approximate their fair value due to their short maturities. The carrying amount of the Company’s debt approximates fair value because the interest rates on these instruments approximate the interest rate on debt with similar terms available to the Company. The Company analyzes all financial instruments with features of both liabilities and equity under ASC 480, “Distinguishing Liabilities from Equity” and ASC 815, “Derivatives and Hedging”. Derivative liabilities are adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjustments to fair value of derivatives. The effects of interactions between embedded derivatives are calculated and accounted for in arriving at the overall fair value of the financial instruments. Also, the fair value of freestanding derivative instruments such as warrant and option derivatives are valued using the Black-Scholes simulation model. The Company’s derivative liabilities were adjusted to fair market value at the end of each reporting period, using Level 3 inputs. The following table sets forth by level with the fair value hierarchy the Company’s financial assets and liabilities measured at fair value on June 30, 2020: Level 1 Level 2 Level 3 Total Liabilities Derivative financial instruments $ - $ - $ 2,134,395 $ 2,134,395 The following table sets forth by level with the fair value hierarchy the Company’s financial assets and liabilities measured at fair value on September 30, 2019: Level 1 Level 2 Level 3 Total Liabilities Derivative financial instruments $ - $ - $ 2,545,735 $ 2,545,735

Leases

Leases	9 Months Ended
	Jun. 30, 2020
Leases [Abstract]
Leases	Note 4 –leases The Company determines if an arrangement is a lease at inception and has lease agreements for warehouses, office facilities, and equipment. These commitments have remaining non-cancelable lease terms, with lease expirations that range from 2020 to 2024. As a result of the adoption of ASC 842, certain real estate and equipment operating leases have been recorded on the balance sheet with a lease liability and right-of-use asset (“ROU”). Application of this standard resulted in the recognition of ROU assets of $1,832,856, net of accumulated amortization, and a corresponding lease liability of $1,886,722. Accounting for finance leases is substantially unchanged. Operating leases are included in operating lease ROU assets, operating lease obligations, current, and operating lease obligations, long term on the condensed consolidated balance sheets. Finance leases are included in property and equipment, finance lease obligations, short term, and finance lease obligations, long term, on the condensed consolidated balance sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make scheduled lease payments. ROU assets and liabilities are recognized on the lease commencement date based on the present value of lease payments over the lease term. The present value of lease payments is calculated using the incremental borrowing rate at lease commencement, which takes into consideration recent debt issuances as well as other applicable market data available. Amortization of lease assets is included in general and administrative expenses. The future minimum lease payments of lease liabilities as of June 30, 2020, are as follows: For the years ended September 30, Operating Leases Financing Leases 2020 972,244 430,591 2021 697,436 514,152 2022 549,390 183,020 2023 347,745 206,674 2024 and thereafter 27,911 5,022 Total lease payments 2,594,726 1,339,450 Less: Payments Made (708,004 ) (307,783 ) Total Lease Liabilities $ 1,886,722 1,031,667

Intangible Assets

Intangible Assets	9 Months Ended
	Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Note 5 – INTANGIBLE ASSETS The Company’s intangible assets consist of customer lists, testing licenses, favorable leases, and websites. The components of intangible assets as of June 30, 2020, and September 30, 2019 consist of: June 30, 2020 September 30, Customer list $ - $ 854,014 License - 503,000 Favorable lease - 3,100 Domains & Websites - 49,516 Non-compete agreements - 182,388 Assembled Workforce - 50,750 Intellectual Property - 342,610 Total - 1,977,661 Accumulated amortization - (1,977,661 ) Net value $ - $ - The Company had fully amortized all intangible assets during the fiscal year ended September 30, 2019.

Concentration of Credit Risk

Concentration of Credit Risk	9 Months Ended
	Jun. 30, 2020
Risks and Uncertainties [Abstract]
Concentration of Credit Risk	Note 6 – Concentration of Credit Risk Instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits, notes receivable and accounts receivable. As of June 30, 2020, the Company did not hold cash at any financial institution in excess of the amount insured by the Federal Deposit Insurance Corporation (“FDIC”) of up to $250,000. As of June 30, 2020, the Company had total accounts receivable net of allowances of $146,443. Five clients comprised a total of 21% of this balance as follows: Balance Percent of Total Customer 1 $ 20,321 6 % Customer 2 14,923 5 % Customer 3 12,000 4 % Customer 4 11,955 3 % Customer 5 11,284 3 % All others 250,945 79 % Total 317,108 100 % Allowance for doubtful accounts (170,666 ) Net accounts receivable $ 146,443 As of September 30, 2019, the Company had total accounts receivable, net of allowances, of $133,022. Five separate clients comprised a total of 41% of this balance as follows: Balance Percent of Total Customer 1 $ 48,606 14 % Customer 2 33,572 10 % Customer 3 20,336 6 % Customer 4 20,321 6 % Customer 5 20,208 6 % All others 246,456 59 % Total 348,955 100 % Allowance for doubtful accounts (215,933 ) Net accounts receivable $ 133,022

Property and Equipment

Property and Equipment	9 Months Ended
	Jun. 30, 2020
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 7 – Property and Equipment Property and equipment are carried at cost. Expenditures for maintenance and repairs are expensed in the period incurred. Renewals and betterments that materially extend the life of the assets are capitalized. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in income for the period. Depreciation is computed for financial statement purposes on a straight-line basis over estimated useful lives of the related assets and the modified accelerated cost recovery system for federal income tax purposes. The estimated useful lives of depreciable assets are: Estimated Useful Lives Building 39 years Laboratory and Computer Equipment 5 years Furniture and Fixtures 7 years Software 3 years Domains 15 years The Company’s property and equipment consisted of the following as of June 30, 2020, and September 30, 2019: June 30, 2020 September 30, 2019 Assets Not-In-Service $ $ - Capital Assets 1,786,949 1,800,347 Land 212,550 212,550 Buildings & Real Estate 941,857 941,857 Furniture and Equipment 152,933 152,933 Laboratory Equipment 2,223,244 2,188,828 Software 82,899 78,996 Computers 31,939 Leasehold Improvements 696,325 697,333 Vehicles 183,589 83,915 Total 6,312,285 6,188,777 Accumulated depreciation (2,339,541 ) (1,511,973 ) Net value $ 3,972,744 $ 4,676,804

Related Party Transactions

Related Party Transactions	9 Months Ended
	Jun. 30, 2020
Related Party Transactions [Abstract]
Related Party Transactions	Note 8 – Related Party Transactions During the periods ended June 30, 2020 and September 30, 2019 the Company received loans from its Chief Operating Officer totaling $40,014 and $194,820, respectively, and made repayments totaling $0 and $1,040, respectively. There was $181,676 and $143,780 due as of June 30, 2020, and September 30, 2019, respectively, and are included in the accompanying consolidated balance sheets as a current portion of notes payable to related parties. The loans carry a 0% interest rate and are due on demand. During the periods ended June 30, 2020 and September 30, 2019 the Company received loans from its Chief Executive Officer totaling $14,000 and $75,000, respectively, and made repayments totaling $5,750 and $19,200, respectively. There was $64,050 and $55,800 due as of June 30, 2020, and September 30, 2019, respectively, and are included in the accompanying consolidated balance sheets as a current portion of notes payable to related parties. The loans carry a 0% interest rate and are due on demand. During the periods ended June 30, 2020, and September 30, 2019, the Company made payments to Sara Lausmann, associated with the asset purchase of Oregon Analytical Services, LLC, totaling $2,000 and $0, respectively. There was $566,289 and $568,299 of principal due as of June 30, 2020 and September 30, 2019, respectively. The note carries interest at a rate of 5% per annum and had accrued interest totaling $122,095 and $107,899 due as of June 30, 2020, and September 30, 2019, respectively. During the periods ended June 30, 2020, and September 30, 2019, the Company made payments to Anthony Smith, our Chief Science Officer, associated with the purchase of 80% of Smith Scientific Industries, totaling $63,662 and $55,090, respectively. There was $117,247 and $180,910 of principal due as of June 30, 2020 and September 31, 2019, respectively. The note carries interest at a rate of 5% per annum and had accrued interest totaling $43,290 and $41,600 due as of June 30, 2020, and September 30, 2019, respectively. During the periods ended June 30, 2020, and September 30, 2019, the Company made repayments to Henry Grimmett, prior Company Director (retired April 2018), on an outstanding loan from member assumed by the Company, totaling a note payable of Greenhaus Analytical Services, LLC, totaling $0 and $3,859, respectively. There was $113,554 and $113,554 of principal due as of June 30, 2020 and September 30, 2019, respectively. The note bears interest at 0% per annum and requires repayments of $25,000 quarterly. During the periods ended June 30, 2020, and September 30, 2019, the Company made no payments to Henry Grimmett, prior Company Director (retired April 2018), associated with the acquisition of Greenhaus Analytical Services, LLC. The Company entered into a $340,000 note payable as part of its acquisition of Greenhaus Analytical Services, LLC. The note carries interest at a rate of 6% per annum and matures on October 16, 2020. During the quarter ended June 30, 2020, a third party purchased the remaining balance of the $170,000 note. During the year ended September 30, 2019, a third party purchased $170,000 of the note from Henry Grimmett, refer to Note 10, Convertible Notes; Noteholder 14. There was $0 and $170,000 of principal due as of June 30, 2020 and September 30, 2019, respectively. Unamortized debt discount of $0 and $25,563 as of June 30, 2020 and September 30, 2019, respectively and $0 and $59,412 of accrued interest due as of June 30, 2020 and September 30, 2019, respectively. During the periods ended June 30, 2020 and September 30, 2019, the Company received loans from a related party associate with Keystone Labs totaling $30,796 and $191,515, respectively, and made repayments totaling $19,248 and $9,034, respectively. There was $355,070 and $354,050 due as of June 30, 2020 and September 30, 2019, respectively. Amounts have been adjusted for USD. The advances are non-interest bearing and due on demand and is included in the accompanying consolidated balance sheets as a current portion of notes payable to related parties.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Stockholders' Equity	Note 9 – STOCKHOLDERS’ EQUITY Series A Convertible Preferred Stock The Company has -0- shares of Series A Convertible Stock issued and outstanding as of June 30, 2020, and September 30, 2019. Series B Convertible Preferred Stock The Company designated 5,000,000 shares of Series B Convertible Preferred Stock (“Series B Preferred Stock”) with a par value of $0.0001 per share. The Company has 5,000,000 shares of Series B Convertible Stock issued and outstanding as of June 30, 2020, and September 30, 2019. These shares converted to common stock at a rate of 1 common share per each share of Series B Convertible Preferred Stock. Series C Convertible Preferred Stock The Company designated 500,000 shares of Series C Convertible Preferred Stock (“Series C Preferred Stock”) with a par value of $0.0001 per share. There were 500,000 shares of Series C Convertible Stock issued and outstanding as of June 30, 2020, and September 30, 2019. These shares converted to common stock at a rate of 5 common shares per each share of Series C Convertible Preferred Stock. Series D Convertible Preferred Stock The Company designated 1,000,000 shares of Series D Convertible Preferred Stock (“Series D Preferred Stock”) with a par value of $0.0001 per share. These shares converted to common stock at a rate of 2.5 common shares per each share of Series D Convertible Preferred Stock. During the Year Ended September 30, 2019, the Company received conversion notices from Series D Preferred Stockholders resulting in a total of 532,500 shares of common stock being issued for the conversion of 213,000 shares of Series D Preferred Stock. There were 349,500 shares of Series D Convertible Stock issued and outstanding as of June 30, 2020, and September 30, 2019, respectively. Common Stock During the three months ended June 30, 2020, the Company issued the following common shares: Number of Shares issued Description $ Value 500,000 Issuance of shares in exchange for consulting, professional and services 5,000 5,000,000 Shares issued for acquisition of equity interests in subsidiaries 105,000 10,000,000 Issuance of shares in connection with the conversion of debentures 100,000 Total 15,500,000 $ 210,000 During the year ended September 30, 2019, the Company issued 1,038,017 common shares valued at $336,891 for services; 1,415,000 common shares for cash proceeds of $586,000; 287,500 common shares valued at $397,980 as compensation to employees; 31,579 common shares for the settlement of $15,000 of accounts payable; 2,054,887 common shares for the settlement of $687,200 of convertible notes payable; 10,163 for the conversion of $25,110 of convertible accrued interest; 20,000 common shares for issuance of a stock purchase agreement valued at $11,760; 669,362 common shares for the settlement of $388,000 debenture conversions, and 532,500 common shares for the conversion of Preferred Series D stock. All conversions of outstanding principal and accrued interest on convertible notes payable were done so at contractual terms. There were 94,217,473 and 29,314,419 shares of common stock issued and outstanding at June 30, 2020, and September 30, 2019

Loans Payable

Loans Payable	9 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Loans Payable	Note 10 – LOANS PAYABLE The Company had the following loans payable outstanding as of June 30, 2020, and September 30, 2019: June 30, 2020 September 30, 2019 On March 16, 2018, the Company executed notes payable for the purchase of three vehicles. The notes carry interest at 6.637% annually and mature on March 31, 2023. 38,269 47,551 On June 28, 2018, the Company executed a note payable for $650,000 for the purchase of the building at 14775 SW 74 th 603,470 622,523 On July 5, 2018, the Company executed a note payable for $750,000 for the asset purchase of MRX Labs. The note carries interest at 8% annually and is due on January 5, 2019. (This note is in default as of 7/5/2019, which resulted in a 5% penalty on outstanding amount.) 750,000 750,000 On October 20, 2019, the Company executed notes payable for the purchase of four vehicles. The notes carry interest at 5.990% annually and mature on December 31, 2023. 98,844 - Total loans payable 1,490,583 1,420,079 Less: current portion of loans payable 788,006 762,476 Long-term portion of loans payable $ 702,577 $ 657,603 As of June 30, 2020 and September 30, 2019, the Company accrued interest of $119,342 and $74,301 respectively

Convertible Notes Payable

Convertible Notes Payable	9 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Convertible Notes Payable	Note 11 – Convertible NOTES PAYABLE The Company has entered into convertible notes payable that convert to common stock of the Company at variable conversion prices. As further discussed in Note 13 – Derivative Liability The following table summarizes all convertible notes outstanding as of June 30, 2020: Holder Issue Date Due Date Principal Unamortized Carrying Value Accrued Interest Noteholder #1 04/24/18 04/24/19 500,000 - 500,000 - Noteholder #2 07/01/19 09/30/19 675,930 - 675,930 61,154 Noteholder #3 08/01/18 01/01/19 396,000 - 396,000 100,253 Noteholder #3 10/02/18 01/01/19 264,000 - 264,000 53,846 Noteholder #5 09/17/18 09/17/19 - - - 10,260 Noteholder #6 11/15/18 11/15/19 - - - 15,564 Noteholder #6 02/04/19 02/04/20 230,000 - 230,000 26,938 Noteholder #6 08/08/19 08/08/20 33,092 (1,282 ) 31,810 2,372 Noteholder #6 11/04/19 11/04/20 33,516 (11,630 ) 21,886 1,756 Noteholder #6 12/23/19 12/23/20 137,375 (66,060 ) 71,315 5,721 Noteholder #6 01/21/20 02/21/21 52,500 (2,500 ) 50,000 2,532 Noteholder #6 02/04/20 02/04/20 265,637 - 265,637 14,774 Noteholder #7 12/27/18 12/27/19 20,000 - 20,000 3,695 Noteholder #7 02/05/19 02/05/20 131,250 - 131,250 14,613 Noteholder #7 02/11/19 02/11/20 131,250 - 131,250 14,325 Noteholder #7 03/15/19 03/15/20 70,913 - 70,913 7,352 Noteholder #7 08/08/19 08/08/20 33,092 (1,282 ) 31,810 2,372 Noteholder #7 11/04/19 11/04/20 33,516 (11,630 ) 21,886 1,756 Noteholder #7 01/03/20 01/03/21 137,375 137,375 5,480 Noteholder #7 01/21/20 02/22/21 52,500 (2,500 ) 50,000 2,532 Noteholder #7 02/04/20 02/04/20 265,637 - 265,637 14,774 Noteholder #10 03/15/19 03/15/20 70,913 - 70,913 7,352 Noteholder #11 08/30/19 05/30/20 110,000 110,000 7,353 Noteholder #11 04/30/20 04/03/21 66,000 (41,900 ) 24,100 1,591 Noteholder #12 01/15/20 04/14/21 100,000 0 100,000 1,372 Noteholder #13 01/24/20 01/23/21 50,000 50,000 - $ 3,860,496 $ (138,784 ) $ 3,721,712 $ 379,737 The following table summarizes all convertible notes outstanding as of September 30, 2019: Holder Issue Date Due Date Principal Unamortized Carrying Value Accrued Interest Noteholder #1 04/24/18 04/24/19 500,000 - 500,000 - Noteholder #2 07/01/19 09/30/19 825,930 - 825,930 18,983 Noteholder #3 08/01/18 01/01/19 396,000 - 396,000 76,471 Noteholder #3 10/02/18 01/01/19 264,000 - 264,000 40,634 Noteholder #4 09/06/18 09/06/19 145,000 - 145,000 15,575 Noteholder #5 09/17/18 09/17/19 82,500 - 82,500 8,586 Noteholder #6 11/15/18 11/15/19 222,600 (28,054 ) 194,546 15,564 Noteholder #6 01/14/19 01/14/20 131,250 (46,027 ) 85,223 7,364 Noteholder #6 02/04/19 02/04/20 265,000 (92,205 ) 172,795 13,824 Noteholder #6 03/15/19 03/15/20 70,913 - 70,913 3,093 Noteholder #6 08/08/19 08/08/20 33,092 (10,291 ) 22,801 384 Noteholder #7 12/27/18 12/27/19 105,000 (25,603 ) 79,397 18,204 Noteholder #7 02/05/19 02/05/20 131,250 (48,185 ) 83,065 6,616 Noteholder #7 03/15/19 03/15/20 70,913 - 70,913 3,093 Noteholder #7 08/08/19 08/08/20 33,092 (10,291 ) 22,801 384 Noteholder #8 02/08/19 02/08/20 783,724 (208,357 ) 575,367 89,627 Noteholder #9 03/15/19 03/15/20 70,913 - 70,913 3,093 Noteholder #10 03/15/19 03/15/20 70,913 - 70,913 3,093 Noteholder #11 08/29/19 05/29/20 100,000 (150,146 ) (50,146 ) 964 Noteholder #11 08/30/19 05/30/20 110,000 (97,555 ) 12,445 747 $ 4,412,090 $ (716,714 ) $ 3,695,376 $ 326,145 Noteholder #1 On April 24, 2018, the Company entered into a convertible note payable totaling $500,000 in exchange for 100% of the assets of Leaf Detective LLC. The note bears no interest, matures on April 24, 2019, and automatically converted to common stock at $1.25 per share on the maturity date. In the event the average lowest trading price of the Company’s common stock during the five days prior to maturity is less than $1.25 per share, the Company will pay the noteholder the difference between $1.25 and the average lowest trading price during the preceding five days per share converted in cash. On or about April 30, 2020, Michele Malaret and Gordon Griswold filed, filed a breach of contract in the original principal amount of $500,000, with the Superior Court of California, County of Humboldt. The Company currently recognizes the full liability on its balance sheet. There is no interest due associated with the note. Noteholder #2 On July 2, 2018, the Company sold and issued a convertible promissory note to an unrelated party for the principal amount of $220,000 of which $20,000 was an original issue discount resulting in cash proceeds to the Company of $200,000 pursuant to the terms of a securities purchase agreement. The note, together with accrued interest at the annual rate of 8%, was due on October 1, 2018. The principal amount of the note and any accrued interest thereon are convertible at the option of the holder into common shares of the Company at any time at a conversion price of $0.60 per share. This note was replaced on July 1, 2019. On September 13, 2018, the Company entered into an exchange agreement with an unrelated party for the principal amount $585,000, of which the loan payable to Palliatech, dated August 1, 2017, outstanding and principal of $549,652 would be assumed by the new note holder, with the difference of $35,348 to be treated as an original issue discount. The new convertible note payable carries an interest rate of 0% per annum is convertible into common stock of the Company at the option of the noteholder immediately at 80% of the lowest volume-weighted average price of the Company’s common stock in the preceding 20 trading days. This note was replaced on July 1, 2019. On July 1, 2019, the two previous notes were replaced for the aggregate principal amount of $825,890. This included a default penalty of $150,000 for non-payment of the prior two notes. The note, together with accrued interest at the annual rate of 8%, is due on September 30, 2019. The note is convertible into common stock of the Company at the option of the noteholder at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $675,930 of principal and $61,154 of accrued interest on June 30, 2020. Noteholder #3 On August 1, 2018, the Company sold and issued a convertible promissory note to an unrelated party for the principal amount of $330,000 of which $30,000 was an original issue discount resulting in cash proceeds to the Company of $300,000 pursuant to the terms of a securities purchase agreement. The note, together with accrued interest at the annual rate of 8%, was due on October 1, 2018. The principal amount of the note and any accrued interest thereon are convertible at the option of the holder into common shares of the Company at any time the lower of a conversion price of $0.50 per share or at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. On September 30, 2019, a fee for payment default of $66,000 was added to the principal. There was $396,000 of principal and $100,253 of accrued interest due on June 30, 2020. On October 2, 2018, the Company sold and issued a convertible promissory note to an unrelated party for the principal amount of $220,000 of which $20,000 was an original issue discount resulting in cash proceeds to the Company of $200,000 pursuant to the terms of a securities purchase agreement. The note, together with accrued interest at the annual rate of 8%, is due on January 1, 2019. The principal amount of the note and any accrued interest thereon are convertible at the option of the holder into common shares of the Company at any time at a conversion price of $0.50 per share or a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. On September 30, 2019, a fee for payment default of $44,000 was added to the principal. There was $264,000 of principal and $53,846 of accrued interest on June 30, 2020. Noteholder #4 On September 6, 2018, the Company sold and issued a convertible promissory note to an unrelated party for the principal amount of $125,000 of which $15,000 was an original issue discount resulting in cash proceeds to the Company of $110,000 pursuant to the terms of a securities purchase agreement. The note, together with accrued interest at the annual rate of 10%, was due on September 6, 2019. The principal amount of the note and any accrued interest thereon are convertible at the option of the holder into common shares of the Company at any time at the lower of a conversion price of $0.50 per share or at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. On July 5, 2019, a fee for payment default of $20,000 was added to the principal. There was no note principal or accrued interest due on June 30, 2020. Noteholder #5 On September 6, 2018, the Company sold and issued a convertible promissory note to an unrelated party for the principal amount of $62,500 of which $6,250 was an original issue discount resulting in cash proceeds to the Company of $56,250 pursuant to the terms of a securities purchase agreement. The note, together with accrued interest at the annual rate of 10%, is due on September 6, 2019. The principal amount of the note and any accrued interest thereon are convertible at the option of the holder into common shares of the Company at any time at the lower of a conversion price of $0.50 per share or at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. On July 5, 2019, a fee for payment default of $20,000 was added to the principal. There was $0 of principal and $10,260 of accrued interest due on June 30, 2020. Noteholder #6 On November 15, 2018, the Company sold and issued a convertible promissory note to an unrelated party for the principal amount of $222,600 of which $12,600 was an original issue discount resulting in cash proceeds to the Company of $210,000 pursuant to the terms of a securities purchase agreement. The note, together with accrued interest at the annual rate of 8%, is due on November 15, 2019. The principal amount of the note and any accrued interest thereon are convertible at the option of the holder into common shares of the Company at any time at the lower of a conversion price of $0.50 per share or at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $0 of principal and $15,564 of accrued interest due on June 30, 2020. On February 4, 2019, the Company entered into a convertible note payable with an unrelated party for $265,000 of which $15,000 was an original issue discount and $10,000 in third party fees resulting in net cash proceeds to the Company of $240,000. The convertible note payable carries interest at a rate of 8% per annum, is due on February 4, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $230,000 of principal and $26,938 accrued interest due on June 30, 2020. On August 8, 2019, the Company entered into a convertible note agreement with an unrelated party for $33,092 of which $1,576 in third party fees resulting in net cash proceeds to the Company of $31,516. The convertible note payable carries interest at a rate of 8% per annum, is due on August 8, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $33,092 of principal and $2,372 of accrued interest due on June 30, 2020. On November 4, 2019, the Company entered into a convertible note agreement with an unrelated party for $33,516 of which $2,000 in third party fees resulting in net cash proceeds to the Company of $31,516. The convertible note payable carries interest at a rate of 8% per annum, is due on November 4, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $33,092 of principal and $1,756 of accrued interest due on June 30, 2020. On December 23, 2019, the Company entered into a convertible note agreement with an unrelated party for $137,375 of which $16,375 in third party fees resulting in net cash proceeds to the Company of $121,000. The convertible note payable carries interest at a rate of 8% per annum, is due on December 23, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $137,375 of principal and $5,721 of accrued interest due on June 30, 2020. On January 21, 2020, the Company entered into a convertible note agreement with an unrelated party for $52,500 of which $2,500 in third party fees resulting in net cash proceeds to the Company of $50,000. The convertible note payable carries interest at a rate of 8% per annum, is due on January 21, 2021, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $52,500 of principal and $2,532 of accrued interest due on June 30, 2020. On February 4, 2020, the Company entered into an exchange agreement with an unrelated party for $265,637, of which the loan payable to Noteholder 8, dated February 8, 2019, outstanding and principal would be assumed by the new note holder. The new convertible note payable carries an interest rate of 8% per annum is due on February 8, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $265,637 of principal and $14,774 of accrued interest due on June 30, 2020. Noteholder #7 On December 27, 2018, the Company sold and issued a Convertible Promissory to an unrelated party for the principal amount of $105,000 pursuant to the terms of a Securities Purchase Agreement of even date therewith. The Note, together with accrued interest at the annual rate of 8%, is due on December 27, 2019, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $20,000 of principal and $3,695 of accrued interest due on June 30, 2020. On February 5, 2019, the Company entered into a convertible note payable with an unrelated party for $131,250 of which included $6,250 in third party fees resulting in net cash proceeds to the Company of $125,000. The convertible note payable carries interest at a rate of 8% per annum, is due on February 5, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $131,250 of principal and $14,613 of accrued interest due on June 30, 2020. On February 11, 2019, the Company entered into a convertible note payable with an unrelated party for $131,250 of which included $6,250 in third party fees resulting in net cash proceeds to the Company of $125,000. The convertible note payable carries interest at a rate of 8% per annum, is due on January 14, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $131,250 of principal and $14,325 of accrued interest due on June 30, 2020. On March 15, 2019, the Company entered into an exchange agreement with an unrelated party for $70,913, of which the loan payable to Noteholder 2, dated July 2, 2018, outstanding and principal would be assumed by the new note holder. The new convertible note payable carries an interest rate of 8% per annum is due on March 15, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $70,913 of principal and $7,352 of accrued interest due on June 30, 2020. On August 8, 2019, the Company entered into a convertible note agreement with an unrelated party for $33,092 of which $1,576 in third party fees resulting in net cash proceeds to the Company of $31,516. The convertible note payable carries interest at a rate of 8% per annum, is due on August 8, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $33,092 of principal and $2,372 of accrued interest due on June 30, 2020. On November 4, 2019, the Company entered into a convertible note agreement with an unrelated party for $33,516 of which $2,000 in third party fees resulting in net cash proceeds to the Company of $31,516. The convertible note payable carries interest at a rate of 8% per annum, is due on November 4, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $33,092 of principal and $1,756 of accrued interest due on June 30, 2020. On January 3, 2020, the Company entered into a convertible note agreement with an unrelated party for $137,375 of which $16,375 in third party fees resulting in net cash proceeds to the Company of $121,000. The convertible note payable carries interest at a rate of 8% per annum, is due on December 23, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $137,375 of principal and $5,480 of accrued interest due on June 30, 2020. On January 21, 2020, the Company entered into a convertible note agreement with an unrelated party for $52,500 of which $2,500 in third party fees resulting in net cash proceeds to the Company of $50,000. The convertible note payable carries interest at a rate of 8% per annum, is due on January 21, 2021, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $52,500 of principal and $2,532 of accrued interest due on June 30, 2020. On February 4, 2020, the Company entered into an exchange agreement with an unrelated party for $265,637, of which the loan payable to Noteholder 8, dated February 8, 2019, outstanding and principal would be assumed by the new note holder. The new convertible note payable carries an interest rate of 8% per annum is due on February 8, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $265,637 of principal and $14,774 of accrued interest due on June 30, 2020. Noteholder #8 On February 8, 2019, the Company entered into an exchange agreement with an unrelated party for $580,537, of which the loan payable to Palliatech, dated September 1, 2017, outstanding and principal would be assumed by the new note holder. The new convertible note payable carries an interest rate of 10% per annum, with one-year interest guaranteed, is due on February 8, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 30% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. A principal non-pay default was applied in the amount of $203,188. This remaining balance of this note was purchased by Noteholder 6 & 7, on February 4, 2020. There was no note principal or accrued interest due on June 30, 2020. Noteholder #9 On March 15, 2019, the Company entered into an exchange agreement with an unrelated party for $70,913, of which the loan payable to Noteholder 2, dated July 2, 2018, outstanding and principal would be assumed by the new note holder. The new convertible note payable carries an interest rate of 8% per annum is due on March 15, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was no note principal or accrued interest due on June 30, 2020. Noteholder #10 On March 15, 2019, the Company entered into an exchange agreement with an unrelated party for $70,913, of which the loan payable to Noteholder 2, dated July 2, 2018, outstanding and principal would be assumed by the new note holder. The new convertible note payable carries an interest rate of 8% per annum is due on March 15, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $70,913 of principal and $7,352 of accrued interest due on June 30, 2020. Noteholder #11 On August 30, 2019, the Company entered into a convertible note payable with an unrelated party for $110,000 which included $10,000 original issue discount resulting in net cash proceeds to the Company of $100,000. The convertible note payable carries interest at a rate of 8% per annum, is due on May 30, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $110,000 of principal and $7,353 of accrued interest due on June 30, 2020. On August 29, 2019, the Company entered into an exchange agreement with an unrelated party for $170,000, of which the loan payable to Henry Grimmett, dated October 16, 2016, outstanding and principal would be assumed by the new note holder. The new convertible note payable carries an interest rate of 8% per annum, is due on May 29, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $100,000 principal and $0 of accrued interest due on June 30, 2020. On April 3, 2020, the Company entered into a convertible note payable with an unrelated party for $66,000 which included $6,000 original issue discount resulting in net cash proceeds to the Company of $60,000. The convertible note payable carries interest at a rate of 10% per annum, is due on April 3, 2021, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company’s common stock in the preceding 15 trading days. There was $66,000 of principal and $1,591 of accrued interest due on June 30, 2020. Noteholder #12 On January 15, 2020, the Company entered into a convertible note payable with an unrelated party for $100,000. The convertible note payable carries interest at a rate of 0% per annum, is due on January 23, 2021, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 20% discount from the lowest trading price of the Company’s common stock in the preceding 5 trading days. There was $100,000 of principal and $1,372 of accrued interest due on June 30, 2020. Noteholder #13 On January 24, 2020, the Company entered into a convertible note payable with an unrelated party for $50,000. The convertible note payable carries interest at a rate of 0% per annum, is due on January 23, 2021, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 20% discount from the lowest trading price of the Company’s common stock in the preceding 5 trading days. There was $50,000 of principal and $0 of accrued interest due on June 30, 2020.

Convertible Debentures

Convertible Debentures	9 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Convertible Debentures	NOTE 12 – CONVERTIBLE DEBENTURES On January 29, 2018, the Company issued a total of 5,973 units of 8% unsecured convertible debentures. Each unit consists of one convertible debenture with a principal face value of $1,000 and 250 warrants. The gross proceeds were $5,973,000. Each warrant entitles the holder thereof to purchase one additional common share of the Company at an exercise price of $0.80 per warrant for 24 months. The convertible debentures have a maturity date of 36 months from issuance. Simple interest will be paid at a rate of 8% per annum in arrears until maturity or until conversion. The principal amount of the debentures and any accrued interest thereon are convertible at the option of the holder into common shares of the Company at any time at a conversion price of $0.60 per share. In addition to the warrants associated with the convertible debentures, the Company issued an additional 597,300 warrants to purchase common stock of the Company as offering costs representing an equivalent of 6% of the fully converted debentures. The warrants are exercisable at $0.60 per share for two years. The Company also issued three separate debentures under the same terms for additional cash proceeds of $610,000. The additional debentures carry an additional 152,500 warrants to purchase additional common shares of the Company at $0.80 per share. Additionally, the outstanding principal and interest may be converted to common stock of the Company at $0.60 per share.

Derivative Liability

Derivative Liability	9 Months Ended
	Jun. 30, 2020
Derivative Liability [Abstract]
Derivative Liability	Note 13 – Derivative Liability As of June 30, 2020 and September 30, 2019, Company had a derivative liability balance of $2,134,395 and $2,545,735 on the balance sheets and recorded an unrealized gain of $411,340 and an unrealized loss of $556,647 from derivative liability fair value adjustments during the nine months ended June 30, 2020 and 2019, respectively. On November 15, 2018, the Company issued a $222,600 convertible promissory note to an unrelated party that matures on November 15, 2019. Refer to Noteholder 6 under “Note 12 – Convertible Debentures” Derivatives and Hedging The embedded derivative for the note is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the embedded derivative using the Black-Scholes option pricing model. The aggregate fair value of the derivative at the issuance date of the note was $220,463 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $184,957 which was up to the face value of the convertible note with the excess fair value at an initial measurement of $35,506 being recognized as a loss on derivative fair value measurement. On December 27, 2018, the Company issued a $105,000 convertible promissory note to an unrelated party that matures on December 27, 2019. Refer to Noteholder 7 under “Note 12 – Convertible Debentures” The aggregate fair value of the derivative at the issuance date of the note was $98,091 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $38,365 which was up to the face value of the convertible note with the excess fair value at an initial measurement of $59,725 being recognized as a loss on derivative fair value measurement. On January 14, 2019, the Company issued a $131,250 convertible promissory note to an unrelated party that matures on February 5, 2020. Refer to Noteholder 6 under “Note 12 – Convertible Debentures” The aggregate fair value of the derivative at the issuance date of the note was $144,752 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $14,423 which was up to the face value of the convertible note with the excess fair value at an initial measurement of $130,329 being recognized as a loss on derivative fair value measurement On February 4, 2019, the Company issued a $265,000 convertible promissory note to an unrelated party that matures on February 4, 2020. Refer to Noteholder 6 under “Note 12 – Convertible Debentures” The aggregate fair value of the derivative at the issuance date of the note was $322,521 which was recorded as a derivative liability on the balance sheet. The Company recognized a loss of $322,521 on derivative fair value measurement. On February 5, 2019, the Company issued a $131,250 convertible promissory note to an unrelated party that matures on February 11, 2020. Refer to Noteholder 7 under “Note 12 – Convertible Debentures” The aggregate fair value of the derivative at the issuance date of the note was $228,916 which was recorded as a derivative liability on the balance sheet. The Company recognized a loss of $228,916 on derivative fair value measurement. On July 1, 2019, the Company issued a $825,930 convertible promissory note to an unrelated party that matures on September 30, 2019. Refer to Noteholder 2 under “Note 12 – Convertible Debentures” The aggregate fair value of the derivative at the issuance date of the note was $1,807,875 which was recorded as a derivative liability on the balance sheet. The Company recognized a loss of $1,807,875 on derivative fair value measurement. On August 8, 2019, the Company issued a $33,092 convertible promissory note to an unrelated party that matures on August 8, 2020. Refer to Noteholder 6 under “Note 12 – Convertible Debentures” The aggregate fair value of the derivative at the issuance date of the note was $34,341 which was recorded as a derivative liability on the balance sheet. The Company recognized a loss of $34,341 on derivative fair value measurement. On August 8, 2019, the Company issued a $33,092 convertible promissory note to an unrelated party that matures on August 8, 2020. Refer to Noteholder 7 under “Note 12 – Convertible Debentures” The aggregate fair value of the derivative at the issuance date of the note was $34,341 which was recorded as a derivative liability on the balance sheet. The Company recognized a loss of $34,341 on derivative fair value measurement. On August 29, 2019, the Company issued a $170,000 convertible promissory note to an unrelated party that matures on May 29, 2020. Refer to Noteholder 14 under “Note 12 – Convertible Debentures” The aggregate fair value of the derivative at the issuance date of the note was $143,951 which was recorded as a derivative liability on the balance sheet. The Company recognized a loss of $65,965 on derivative fair value measurement. On August 30, 2019, the Company issued a $110,000 convertible promissory note to an unrelated party that matures on May 30, 2020. Refer to Noteholder 11 under “Note 12 – Convertible Debentures” The aggregate fair value of the derivative at the issuance date of the note was $109,936 which was recorded as a derivative liability on the balance sheet. The Company recognized a loss of $79,183 on derivative fair value measurement. On November 4, 2019, the Company issued a $33,516 convertible promissory note to an unrelated party that matures on November 4, 2020. Refer to Noteholder 6 under “Note 12 – Convertible Debentures” The aggregate fair value of the derivative at six months from issuance date of the note was $33,516 which was recorded as a derivative liability on the balance sheet. The Company recognized a loss of $17,021 on derivative fair value measurement. On November 4, 2019, the Company issued a $33,516 convertible promissory note to an unrelated party that matures on November 4, 2020. Refer to Noteholder 7 under “Note 12 – Convertible Debentures” The aggregate fair value of the derivative at six months from issuance date of the note was $33,516 which was recorded as a derivative liability on the balance sheet. The Company recognized a loss of $17,021 on derivative fair value measurement. On December 23, 2019, the Company issued a $137,375 convertible promissory note to an unrelated party that matures on December 23, 2020. Refer to Noteholder 6 under “Note 12 – Convertible Debentures” The aggregate fair value of the derivative at six months from issuance date of the note was $204,554 which was recorded as a derivative liability on the balance sheet. The Company recognized a loss of $204,554 on derivative fair value measurement. On April 3, 2020, the Company issued a $66,000 convertible promissory note to an unrelated party that matures on November 30, 2020. Refer to Noteholder 11 under “Note 12 – Convertible Debentures” The aggregate fair value of the derivative at the issuance date of the note was $78,115 which was recorded as a derivative liability on the balance sheet. The Company recognized a loss of $67,96 on derivative fair value measurement. At June 30, 2020, the Company marked-to-market the fair value of the derivative liabilities related to conversion features and determined an aggregate fair value of $2,134,395 and recorded a $332,993 gain from change in fair value for the nine months ended June 30, 2020. The fair value of the embedded derivatives was determined using a Black-Scholes option pricing model based on the following assumptions: (1) expected volatility of 168%, (2) risk-free interest rate of 0.16%, (3) exercise prices of $0.011 - $0.019, and (4) expected lives of 0.11 – 0.50 of a year. On October 2, 2018, the Company issued a total of $220,000 convertible debenture to an unrelated party that matures on January 1, 2019. The Company issued a total of 100,000 warrants to purchase additional shares of common stock of the Company in connection with the convertible debenture. The Company analyzed the issued warrants for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the warrants should be classified as a derivative because the Company is unable to ascertain there will be adequate unissued authorized shares of common stock to fulfill its obligations should the warrants be exercised. In accordance with AC 815, the Company has recorded a derivative liability related to the warrants. The derivative for the warrants is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the derivative using the Black-Scholes option pricing model. The aggregate fair value of the derivative at the issuance date of the warrants was $57,014 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $53,333 which was up to the face value of the convertible debentures with the excess fair value at an initial measurement of $3,681 being recognized as a loss on derivative fair value measurement. As discussed in “Note 12 – Convertible Debentures” At June 30, 2020, the Company marked-to-market the fair value of the derivative liabilities related to warrants and determined an aggregate fair value of $44 and recorded a $181,772 gain from change in fair value for the six months ended June 30, 2020. The fair value of the derivatives was determined using a Black-Scholes option pricing model based on the following assumptions: (1) expected volatility of 168%, (2) risk-free interest rate of 0.16%, (3) exercise prices of $0.60 to $0.80, and (4) expected lives of 0.26 – 0.30 years. The following table summarizes the change in derivative liabilities included in the balance sheet at June 30, 2020: Fair Value of Embedded Derivative Liabilities: Balance, September 30, 2019 $ 2,545,735 Change in fair market value (411,340 ) Balance, June 30, 2020 $ 2,134,395 The following table summarizes the gain (loss) on derivative liability included in the income statement for the nine months ended June 30, 2020 and 2019, respectively. Nine Months Ended June 30, 2020 2019 Day one loss due to derivatives on convertible debt $ (414,478 ) (780,678 ) Change in fair value of derivatives 825,818 1,225,743 Total derivative gain (loss) $ 411,340 445,065

Stock Options and Warrants

Stock Options and Warrants	9 Months Ended
	Jun. 30, 2020
Stock Options And Warrants
Stock Options and Warrants	NOTE 14 – STOCK OPTIONS AND WARRANTS The following tables summarize all stock option and warrant activity for the three months ended June 30, 2020: Shares Weighted- Average Exercise Price Per Share Outstanding, September 30, 2019 5,484,970 0.742 Granted - - Exercised - - Forfeited - - Expired - - Outstanding, June 30, 2020 5,484,970 0.742 The following table discloses information regarding outstanding and exercisable options and warrants at June 30, 2020: Outstanding Exercisable Exercise Prices Number of Option Shares Weighted Average Weighted Average Remaining Life (Years) Number of Option Shares Weighted Average $ 0.225 200,000 $ 0.225 4.46 200,000 $ 0.225 $ 0.400 110,000 $ 0.400 1.62 110,000 $ 0.400 $ 0.420 330,000 $ 0.420 4.05 330,000 $ 0.420 $ 0.500 165,000 $ 0.500 1.70 162,500 $ 0.500 $ 0.600 627,220 $ 0.600 0.11 627,220 $ 0.600 $ 0.650 145,000 $ 0.650 2.82 36,250 $ 0.650 $ 0.800 3,482,750 $ 0.800 1.43 3,095,250 $ 0.800 $ 0.850 100,000 $ 0.850 3.29 - $ 0.850 $ 1.050 25,000 $ 1.050 3.79 - $ 1.050 $ 1.260 220,000 $ 1.260 2.50 110,000 $ 1.260 $ 1.300 10,000 $ 1.300 1.80 7,500 $ 1.300 $ 1.386 60,000 $ 1.386 2.50 30,000 $ 1.386 $ 1.666 10,000 $ 1.666 2.59 5,000 $ 1.666 Total 5,484,970 $ 0.742 1.95 4,713,720 $ 0.718 Compensation related to stock-based compensation was $126,581 and $169,922, respectively, for the three months ended June 30, 2020 and 2019.

Subsequent Events

Subsequent Events	9 Months Ended
	Jun. 30, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 15 – Subsequent Events Common Stock Issuances The Company made the following issuances of common stock subsequent to June 30, 2020: None Legal Proceedings From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. On February 6, 2020, MC CRE Investments, LLC landlord for the Palm Desert location, filed a Breach of Lease Agreement with the Superior Court of the State of California, County of Riverside. EVIO Labs Palm Desert has vacated the space and turned it back over to the landlord. The Company has expensed past due rents and late fees and these items are included in the liabilities in the balance sheet. On or about March 5, 2020, Paul Tomaso, and Jonah Barber beneficiaries for MRX Labs, LLC, filed a Breach of Promissory Note in the original principal amount of $750,000, plus late fees and penalties, with the Circuit Court of the State in Oregon, in Multnomah County against Greenhaus Analytical Labs, LLC. The Company has expensed penalties and late fees and these items are included in the liabilities in the balance sheet. On or about April 30, 2020, Michele Malaret and Gordon Griswold filed, filed a Breach of Contract in the original principal amount of $500,000, with the Superior Court of California, County of Humboldt. The Company currently recognizes the full liability on its balance sheet. There is no interest due associated with the note.

Organization, Basis of Presen_2

Organization, Basis of Presentation and Significant Accounting Policies (Policies)	9 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Management's Representation of Interim Financial Statements	Management’s Representation of Interim Financial Statements The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission and should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s most recent Annual Financial Statements filed with the SEC on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim period presented have been reflected herein. The results of operations for the interim period are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosures contained in the audited consolidated financial statements for the most recent fiscal period, as reported in the Form 10-K, have been omitted.
Basis of Presentation	Basis of Presentation The consolidated financial statements of the Company have been prepared in accordance with GAAP and are expressed in United States dollars. For the three months ended June 30, 2020, and 2019, and the year ended September 30, 2019, the consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. The subsidiaries of EVIO, Inc. are as follows: Trade Name (dba) Company Name State of Ownership % Acquisition Month EVIO Labs Medford Smith Scientific Industries, LLC Oregon 80 % June 2016 EVIO Labs Portland Greenhaus Analytical Labs Oregon 100 % October 2016 EVIO Labs MA Viridis Analytics Massachusetts 100 % August 2017 EVIO Labs Berkeley C3 Labs, LLC California 90 % January 2018 Keystone Labs Keystone Labs, Inc. Ontario, Canada 50 % May 2018
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers. The core principle of the new revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied to achieve that core principle: ● Step 1: Identify the contract with the customer ● Step 2: Identify the performance obligations in the contract ● Step 3: Determine the transaction price ● Step 4: Allocate the transaction price to the performance obligations in the contract ● Step 5: Recognize revenue when the company satisfies a performance obligation The Company generates revenue from consulting services, licensing agreements, and testing of cannabis and hemp products for medicinal and adult-use consumption. The Company accounts for a contract after it has been approved by all parties to the arrangement, the rights of the parties are identified, payment terms are identified, the contract has commercial substance, and collectability of consideration is probable. The Company evaluates the services promised in each contract at inception to determine whether the contract should be accounted for as having one or more performance obligations. The Company’s services included in its contracts are distinct from one another. The Company determines the transaction price for each contract based on the consideration it expects to receive for the distinct services being provided under the contract. The Company recognizes revenue as performance obligations are satisfied and the customer obtains control of the services provided. In determining when performance obligations are satisfied, the Company considers factors such as contract terms, payment terms, and whether there is an alternative future use of the service. The Company recognizes revenue from testing services upon delivery of its testing results to the client. Customer orders for testing services are generally completed within two weeks of receiving the order. Consulting engagements may vary in length and scope, but will generally include the review and/or preparation of regulatory filings, business plans, and financial models, operating plans, and technology support to customers within the same industry. Revenue from consulting services is recognized upon completion of deliverables as outlined in the consulting agreement. The Company recognizes revenue from the right of use license agreements upon transfer of control of the functional intellectual property. In certain licensing agreements, the Company may receive royalty revenues based upon performance metrics which are recognized as earned over time.
Stock-Based Compensation	Stock-Based Compensation In accordance with ASC No. 718, Compensation-Stock Compensation (“ASC 718”), the Company measures the cost of stock-based compensation arrangements based on the grant date fair value and recognizes the cost in the financial statements over the period during which employees are required to provide services. Stock-based compensation arrangements may include stock options, restricted stock plans, performance-based awards, stock appreciation rights, and employee stock purchase plans. The Company utilizes the Black Scholes option pricing model, which was developed for use in estimating the fair value of options. Option pricing models require the input of highly complex and subjective variables including the expected life of options granted and the expected volatility of the Company’s stock price over a period equal to or greater than the expected life of the options.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are recorded at their original invoice amounts. We regularly review collectability and establish an allowance for uncollectible amounts as necessary based on our experience with historical collectability. Management recognized an allowance for uncollectible amounts, of $170,666 and $215,593 for the periods ended June 30, 2020, and September 30, 2019, respectively.
Foreign Currency Translation	Foreign Currency Translation The functional currency of the Company’s subsidiary in Canada is the Canadian Dollar. The subsidiary’s assets and liabilities have been translated to U.S. Dollars using the exchange rates in effect at the balance sheet dates. Statements of operations amounts have been translated using the average exchange rate for each period. Resulting gains or losses from translating foreign currency financial statements are recorded as other comprehensive income (loss).
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company has adopted the guidance under ASC Topic 820 for financial instruments measured on fair value on a recurring basis. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.
Net Income (Loss) Per Share	Net Income (Loss) Per Share Basic loss per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. There were 94,142,473 and 26,160,911 potentially dilutive common shares outstanding as of June 30, 2020 and 2019, respectively. Because of the net losses incurred during the three months ended June 30, 2020, and 2019, the impacts of dilutive instruments would have been anti-dilutive for the period presented and have been excluded from the diluted loss per share calculations.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In January 2017, the FASB issued ASU 2017-04, “ Intangibles—Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment”. In January 2017, the FASB issued ASU 2017-01, “ Business Combinations (Topic 805): Clarifying the Definition of a Business, In June 2018, the FASB issued ASU 2018-07, Compensation-Stock Compensation (Topic 718) Compensation-Stock Compensation Revenue from Contracts with Customers In August 2018, the SEC issued Final Rule Release No. 33-10532, Disclosure Update, and Simplification. Under the final rule Company’s must now analyze changes in stockholders’ equity in the form of a reconciliation, for the current and comparative year-to-date, with subtotals for each interim period. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our financial statements upon adoption.

Organization, Basis of Presen_3

Organization, Basis of Presentation and Significant Accounting Policies (Tables)	9 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Schedule of Subsidiaries	The subsidiaries of EVIO, Inc. are as follows: Trade Name (dba) Company Name State of Ownership % Acquisition Month EVIO Labs Medford Smith Scientific Industries, LLC Oregon 80 % June 2016 EVIO Labs Portland Greenhaus Analytical Labs Oregon 100 % October 2016 EVIO Labs MA Viridis Analytics Massachusetts 100 % August 2017 EVIO Labs Berkeley C3 Labs, LLC California 90 % January 2018 Keystone Labs Keystone Labs, Inc. Ontario, Canada 50 % May 2018

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Jun. 30, 2020
Investments, All Other Investments [Abstract]
Schedule of Assets and Liabilities Measured in Fair Value	The following table sets forth by level with the fair value hierarchy the Company’s financial assets and liabilities measured at fair value on June 30, 2020: Level 1 Level 2 Level 3 Total Liabilities Derivative financial instruments $ - $ - $ 2,134,395 $ 2,134,395 The following table sets forth by level with the fair value hierarchy the Company’s financial assets and liabilities measured at fair value on September 30, 2019: Level 1 Level 2 Level 3 Total Liabilities Derivative financial instruments $ - $ - $ 2,545,735 $ 2,545,735

Leases (Tables)

Leases (Tables)	9 Months Ended
	Jun. 30, 2020
Leases [Abstract]
Schedule of Future Minimum Lease Payments of Lease Liabilities	Amortization of lease assets is included in general and administrative expenses. The future minimum lease payments of lease liabilities as of June 30, 2020, are as follows: For the years ended September 30, Operating Leases Financing Leases 2020 972,244 430,591 2021 697,436 514,152 2022 549,390 183,020 2023 347,745 206,674 2024 and thereafter 27,911 5,022 Total lease payments 2,594,726 1,339,450 Less: Payments Made (708,004 ) (307,783 ) Total Lease Liabilities $ 1,886,722 1,031,667

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	The components of intangible assets as of June 30, 2020, and September 30, 2019 consist of: June 30, 2020 September 30, Customer list $ - $ 854,014 License - 503,000 Favorable lease - 3,100 Domains & Websites - 49,516 Non-compete agreements - 182,388 Assembled Workforce - 50,750 Intellectual Property - 342,610 Total - 1,977,661 Accumulated amortization - (1,977,661 ) Net value $ - $ -

Concentration of Credit Risk (T

Concentration of Credit Risk (Tables)	9 Months Ended
	Jun. 30, 2020
Risks and Uncertainties [Abstract]
Schedule of Allowance for Accounts Receivable	As of June 30, 2020, the Company had total accounts receivable net of allowances of $146,443. Five clients comprised a total of 21% of this balance as follows: Balance Percent of Total Customer 1 $ 20,321 6 % Customer 2 14,923 5 % Customer 3 12,000 4 % Customer 4 11,955 3 % Customer 5 11,284 3 % All others 250,945 79 % Total 317,108 100 % Allowance for doubtful accounts (170,666 ) Net accounts receivable $ 146,443 As of September 30, 2019, the Company had total accounts receivable, net of allowances, of $133,022. Five separate clients comprised a total of 41% of this balance as follows: Balance Percent of Total Customer 1 $ 48,606 14 % Customer 2 33,572 10 % Customer 3 20,336 6 % Customer 4 20,321 6 % Customer 5 20,208 6 % All others 246,456 59 % Total 348,955 100 % Allowance for doubtful accounts (215,933 ) Net accounts receivable $ 133,022

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Jun. 30, 2020
Property, Plant and Equipment [Abstract]
Schedule of Estimated Life of Property and Equipment	The estimated useful lives of depreciable assets are: Estimated Useful Lives Building 39 years Laboratory and Computer Equipment 5 years Furniture and Fixtures 7 years Software 3 years Domains 15 years
Schedule of Property and Equipment	The Company’s property and equipment consisted of the following as of June 30, 2020, and September 30, 2019: June 30, 2020 September 30, 2019 Assets Not-In-Service $ $ - Capital Assets 1,786,949 1,800,347 Land 212,550 212,550 Buildings & Real Estate 941,857 941,857 Furniture and Equipment 152,933 152,933 Laboratory Equipment 2,223,244 2,188,828 Software 82,899 78,996 Computers 31,939 Leasehold Improvements 696,325 697,333 Vehicles 183,589 83,915 Total 6,312,285 6,188,777 Accumulated depreciation (2,339,541 ) (1,511,973 ) Net value $ 3,972,744 $ 4,676,804

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Schedule of Issuance of Common Shares	During the three months ended June 30, 2020, the Company issued the following common shares: Number of Shares issued Description $ Value 500,000 Issuance of shares in exchange for consulting, professional and services 5,000 5,000,000 Shares issued for acquisition of equity interests in subsidiaries 105,000 10,000,000 Issuance of shares in connection with the conversion of debentures 100,000 Total 15,500,000 $ 210,000

Loans Payable (Tables)

Loans Payable (Tables)	9 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Schedule of Loans Payable	The Company had the following loans payable outstanding as of June 30, 2020, and September 30, 2019: June 30, 2020 September 30, 2019 On March 16, 2018, the Company executed notes payable for the purchase of three vehicles. The notes carry interest at 6.637% annually and mature on March 31, 2023. 38,269 47,551 On June 28, 2018, the Company executed a note payable for $650,000 for the purchase of the building at 14775 SW 74 th 603,470 622,523 On July 5, 2018, the Company executed a note payable for $750,000 for the asset purchase of MRX Labs. The note carries interest at 8% annually and is due on January 5, 2019. (This note is in default as of 7/5/2019, which resulted in a 5% penalty on outstanding amount.) 750,000 750,000 On October 20, 2019, the Company executed notes payable for the purchase of four vehicles. The notes carry interest at 5.990% annually and mature on December 31, 2023. 98,844 - Total loans payable 1,490,583 1,420,079 Less: current portion of loans payable 788,006 762,476 Long-term portion of loans payable $ 702,577 $ 657,603

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	9 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Schedule of Convertible Notes Payable	The following table summarizes all convertible notes outstanding as of June 30, 2020: Holder Issue Date Due Date Principal Unamortized Carrying Value Accrued Interest Noteholder #1 04/24/18 04/24/19 500,000 - 500,000 - Noteholder #2 07/01/19 09/30/19 675,930 - 675,930 61,154 Noteholder #3 08/01/18 01/01/19 396,000 - 396,000 100,253 Noteholder #3 10/02/18 01/01/19 264,000 - 264,000 53,846 Noteholder #5 09/17/18 09/17/19 - - - 10,260 Noteholder #6 11/15/18 11/15/19 - - - 15,564 Noteholder #6 02/04/19 02/04/20 230,000 - 230,000 26,938 Noteholder #6 08/08/19 08/08/20 33,092 (1,282 ) 31,810 2,372 Noteholder #6 11/04/19 11/04/20 33,516 (11,630 ) 21,886 1,756 Noteholder #6 12/23/19 12/23/20 137,375 (66,060 ) 71,315 5,721 Noteholder #6 01/21/20 02/21/21 52,500 (2,500 ) 50,000 2,532 Noteholder #6 02/04/20 02/04/20 265,637 - 265,637 14,774 Noteholder #7 12/27/18 12/27/19 20,000 - 20,000 3,695 Noteholder #7 02/05/19 02/05/20 131,250 - 131,250 14,613 Noteholder #7 02/11/19 02/11/20 131,250 - 131,250 14,325 Noteholder #7 03/15/19 03/15/20 70,913 - 70,913 7,352 Noteholder #7 08/08/19 08/08/20 33,092 (1,282 ) 31,810 2,372 Noteholder #7 11/04/19 11/04/20 33,516 (11,630 ) 21,886 1,756 Noteholder #7 01/03/20 01/03/21 137,375 137,375 5,480 Noteholder #7 01/21/20 02/22/21 52,500 (2,500 ) 50,000 2,532 Noteholder #7 02/04/20 02/04/20 265,637 - 265,637 14,774 Noteholder #10 03/15/19 03/15/20 70,913 - 70,913 7,352 Noteholder #11 08/30/19 05/30/20 110,000 110,000 7,353 Noteholder #11 04/30/20 04/03/21 66,000 (41,900 ) 24,100 1,591 Noteholder #12 01/15/20 04/14/21 100,000 0 100,000 1,372 Noteholder #13 01/24/20 01/23/21 50,000 50,000 - $ 3,860,496 $ (138,784 ) $ 3,721,712 $ 379,737 The following table summarizes all convertible notes outstanding as of September 30, 2019: Holder Issue Date Due Date Principal Unamortized Carrying Value Accrued Interest Noteholder #1 04/24/18 04/24/19 500,000 - 500,000 - Noteholder #2 07/01/19 09/30/19 825,930 - 825,930 18,983 Noteholder #3 08/01/18 01/01/19 396,000 - 396,000 76,471 Noteholder #3 10/02/18 01/01/19 264,000 - 264,000 40,634 Noteholder #4 09/06/18 09/06/19 145,000 - 145,000 15,575 Noteholder #5 09/17/18 09/17/19 82,500 - 82,500 8,586 Noteholder #6 11/15/18 11/15/19 222,600 (28,054 ) 194,546 15,564 Noteholder #6 01/14/19 01/14/20 131,250 (46,027 ) 85,223 7,364 Noteholder #6 02/04/19 02/04/20 265,000 (92,205 ) 172,795 13,824 Noteholder #6 03/15/19 03/15/20 70,913 - 70,913 3,093 Noteholder #6 08/08/19 08/08/20 33,092 (10,291 ) 22,801 384 Noteholder #7 12/27/18 12/27/19 105,000 (25,603 ) 79,397 18,204 Noteholder #7 02/05/19 02/05/20 131,250 (48,185 ) 83,065 6,616 Noteholder #7 03/15/19 03/15/20 70,913 - 70,913 3,093 Noteholder #7 08/08/19 08/08/20 33,092 (10,291 ) 22,801 384 Noteholder #8 02/08/19 02/08/20 783,724 (208,357 ) 575,367 89,627 Noteholder #9 03/15/19 03/15/20 70,913 - 70,913 3,093 Noteholder #10 03/15/19 03/15/20 70,913 - 70,913 3,093 Noteholder #11 08/29/19 05/29/20 100,000 (150,146 ) (50,146 ) 964 Noteholder #11 08/30/19 05/30/20 110,000 (97,555 ) 12,445 747 $ 4,412,090 $ (716,714 ) $ 3,695,376 $ 326,145

Derivative Liability (Tables)

Derivative Liability (Tables)	9 Months Ended
	Jun. 30, 2020
Derivative Liability [Abstract]
Schedule of Derivative Liabilities	The following table summarizes the change in derivative liabilities included in the balance sheet at June 30, 2020: Fair Value of Embedded Derivative Liabilities: Balance, September 30, 2019 $ 2,545,735 Change in fair market value (411,340 ) Balance, June 30, 2020 $ 2,134,395
Summary of Gain (Loss) on Derivative Liability	The following table summarizes the gain (loss) on derivative liability included in the income statement for the nine months ended June 30, 2020 and 2019, respectively. Nine Months Ended June 30, 2020 2019 Day one loss due to derivatives on convertible debt $ (414,478 ) (780,678 ) Change in fair value of derivatives 825,818 1,225,743 Total derivative gain (loss) $ 411,340 445,065

Stock Options and Warrants (Tab

Stock Options and Warrants (Tables)	9 Months Ended
	Jun. 30, 2020
Stock Options And Warrants
Summary of Stock Option and Warrant Activity	The following tables summarize all stock option and warrant activity for the three months ended June 30, 2020: Shares Weighted- Average Exercise Price Per Share Outstanding, September 30, 2019 5,484,970 0.742 Granted - - Exercised - - Forfeited - - Expired - - Outstanding, June 30, 2020 5,484,970 0.742
Schedule of Outstanding and Exercisable Options and Warrants	The following table discloses information regarding outstanding and exercisable options and warrants at June 30, 2020: Outstanding Exercisable Exercise Prices Number of Option Shares Weighted Average Weighted Average Remaining Life (Years) Number of Option Shares Weighted Average $ 0.225 200,000 $ 0.225 4.46 200,000 $ 0.225 $ 0.400 110,000 $ 0.400 1.62 110,000 $ 0.400 $ 0.420 330,000 $ 0.420 4.05 330,000 $ 0.420 $ 0.500 165,000 $ 0.500 1.70 162,500 $ 0.500 $ 0.600 627,220 $ 0.600 0.11 627,220 $ 0.600 $ 0.650 145,000 $ 0.650 2.82 36,250 $ 0.650 $ 0.800 3,482,750 $ 0.800 1.43 3,095,250 $ 0.800 $ 0.850 100,000 $ 0.850 3.29 - $ 0.850 $ 1.050 25,000 $ 1.050 3.79 - $ 1.050 $ 1.260 220,000 $ 1.260 2.50 110,000 $ 1.260 $ 1.300 10,000 $ 1.300 1.80 7,500 $ 1.300 $ 1.386 60,000 $ 1.386 2.50 30,000 $ 1.386 $ 1.666 10,000 $ 1.666 2.59 5,000 $ 1.666 Total 5,484,970 $ 0.742 1.95 4,713,720 $ 0.718

Organization, Basis of Presen_4

Organization, Basis of Presentation and Significant Accounting Policies (Details Narrative) - USD ($)	9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2019	Dec. 29, 2018	May 29, 2018	May 02, 2018	Oct. 19, 2016	Jun. 01, 2016	Sep. 17, 2015
Allowance for accounts receivable	$ 170,666		$ 215,593
Dilutive common shares outstanding	94,142,473	26,160,911
Share Exchange Agreement [Member] | CR Labs, Inc. [Member]
Ownership percentage									80.00%
Securities Purchase Agreement [Member] | Smith Scientific Industries, Inc. [Member]
Ownership percentage								80.00%
William Waldrop and Lori Glauser, principals of Signal Bay Research, Inc. [Member]
Ownership percentage	80.00%
Minimum percentage of common stock owned	5.00%
Greenhaus Analytical Services, LLC [Member] | Membership Interest Purchase Agreement [Member]
Ownership percentage							100.00%
C3 Labs, LLC [Member] | Membership Purchase Agreement [Member]
Ownership percentage				60.00%
Keystone, Labs, Inc [Member] | Stock Purchase Agreement [Member]
Ownership percentage						50.00%
Viridis Analytics MA [Member] | Membership Interest Purchase Agreement [Member]
Ownership percentage					100.00%

Organization, Basis of Presen_5

Organization, Basis of Presentation and Significant Accounting Policies - Schedule of Subsidiaries (Details)	9 Months Ended
	Jun. 30, 2020
EVIO Labs Medford [Member]
Company Name	Smith Scientific Industries, LLC
State of Incorporation	Oregon
Ownership %	80.00%
Acquisition Month	June 2016
EVIO Labs Portland [Member]
Company Name	Greenhaus Analytical Labs
State of Incorporation	Oregon
Ownership %	100.00%
Acquisition Month	October 2016
EVIO Labs MA [Member]
Company Name	Viridis Analytics
State of Incorporation	Massachusetts
Ownership %	100.00%
Acquisition Month	August 2017
EVIO Labs Berkeley [Member]
Company Name	C3 Labs, LLC
State of Incorporation	California
Ownership %	90.00%
Acquisition Month	January 2018
Keystone Labs [Member]
Company Name	Keystone Labs, Inc.
State of Incorporation	Ontario, Canada
Ownership %	50.00%
Acquisition Month	May 2018

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Schedule of Assets and Liabilities Measured in Fair Value (Details) - USD ($)	Jun. 30, 2020	Sep. 30, 2019
Derivative financial instruments	$ 2,134,395	$ 2,545,735
Level 1 [Member]
Derivative financial instruments
Level 2 [Member]
Derivative financial instruments
Level 3 [Member]
Derivative financial instruments	$ 2,134,395	$ 2,545,735

Leases (Details Narrative)

Leases (Details Narrative) - USD ($)	9 Months Ended
	Jun. 30, 2020	Sep. 30, 2019
Leases [Abstract]
Lease expirations description	These commitments have remaining non-cancelable lease terms, with lease expirations that range from 2020 to 2024.
Right of use assets	$ 1,832,856	$ 2,543,976
Lease Liability	$ 1,886,722	$ 2,594,726

Leases - Schedule of Future Min

Leases - Schedule of Future Minimum Lease Payments of Lease Liabilities (Details)	Jun. 30, 2020USD ($)
Leases [Abstract]
Operating Leases, For the years ended September 30, 2020	$ 972,244
Operating Leases, For the years ended September 30, 2021	697,436
Operating Leases, For the years ended September 30, 2022	549,390
Operating Leases, For the years ended September 30, 2023	347,745
Operating Leases, For the years ended September 30, 2024 and thereafter	27,911
Operating Leases, Total lease payments	2,594,726
Operating Leases, Less: Payments Made	(708,004)
Operating Leases, Total Lease Liabilities	1,886,722
Financing Leases, For the years ended September 30, 2020	430,591
Financing Leases, For the years ended September 30, 2021	514,152
Financing Leases, For the years ended September 30, 2022	183,020
Financing Leases, For the years ended September 30, 2023	206,674
Financing Leases, For the years ended September 30, 2024 and thereafter	5,022
Financing Leases, Total lease payments	1,339,450
Financing Leases, Less: Payments Made	(307,783)
Financing Leases, Total Lease Liabilities	$ 1,031,667

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)	Jun. 30, 2020	Sep. 30, 2019
Total		$ 1,977,661
Accumulated amortization		(1,977,661)
Net value
Customer Lists [Member]
Total		854,014
License [Member]
Total		503,000
Favorable Lease [Member]
Total		3,100
Domains & Websites [Member]
Total		49,516
Non-compete Agreements [Member]
Total		182,388
Assembled Workforce [Member]
Total		50,750
Intellectual Property [Member]
Total		$ 342,610

Concentration of Credit Risk (D

Concentration of Credit Risk (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	Jun. 30, 2020	Sep. 30, 2019
Cash insured by Federal Deposit Insurance Corporation	$ 250,000
Accounts receivable, net	$ 146,443	$ 133,022
Five Seperate Clients [Member] | Accounts Receivable [Member]
Concentration risk percentage	21.00%	41.00%

Concentration of Credit Risk -

Concentration of Credit Risk - Schedule of Allowance for Accounts Receivable (Details) - USD ($)	9 Months Ended	12 Months Ended
	Jun. 30, 2020	Sep. 30, 2019
Gross accounts receivable	$ 317,108	$ 348,955
Allowance for doubtful accounts	(170,666)	(215,933)
Net accounts receivable	$ 110,786	$ 133,022
Credit Concentration Risk [Member]
Concentration of risk percentage	100.00%	100.00%
Customer 1 [Member]
Gross accounts receivable	$ 20,321	$ 48,606
Customer 1 [Member] | Credit Concentration Risk [Member]
Concentration of risk percentage	6.00%	14.00%
Customer 2 [Member]
Gross accounts receivable	$ 14,923	$ 33,572
Customer 2 [Member] | Credit Concentration Risk [Member]
Concentration of risk percentage	5.00%	10.00%
Customer 3 [Member]
Gross accounts receivable	$ 12,000	$ 20,336
Customer 3 [Member] | Credit Concentration Risk [Member]
Concentration of risk percentage	4.00%	6.00%
Customer 4 [Member]
Gross accounts receivable	$ 11,955	$ 20,321
Customer 4 [Member] | Credit Concentration Risk [Member]
Concentration of risk percentage	3.00%	6.00%
Customer 5 [Member]
Gross accounts receivable	$ 11,284	$ 20,208
Customer 5 [Member] | Credit Concentration Risk [Member]
Concentration of risk percentage	3.00%	6.00%
All Others [Member]
Gross accounts receivable	$ 250,945	$ 246,456
All Others [Member] | Credit Concentration Risk [Member]
Concentration of risk percentage	79.00%	59.00%

Property and Equipment - Schedu

Property and Equipment - Schedule of Estimated Life of Property and Equipment (Details)	9 Months Ended
	Jun. 30, 2020
Building [Member]
Property and Equipment, estimated useful life	39 years
Laboratory and Computer Equipment [Member]
Property and Equipment, estimated useful life	5 years
Furniture and Fixtures [Member]
Property and Equipment, estimated useful life	7 years
Software [Member]
Property and Equipment, estimated useful life	3 years
Domains [Member]
Property and Equipment, estimated useful life	15 years

Property and Equipment - Sche_2

Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)	Jun. 30, 2020	Sep. 30, 2019
Total	$ 6,312,285	$ 6,188,777
Accumulated depreciation	(2,339,541)	(1,511,973)
Net value	2,643,460	3,080,426
Assets Not-In-Service [Member]
Total
Capital Assets [Member]
Total	1,786,949	1,800,347
Land [Member]
Total	212,550	212,550
Buildings & Real Estate [Member]
Total	941,857	941,857
Furniture and Equipment [Member]
Total	152,933	152,933
Laboratory Equipment [Member]
Total	2,223,244	2,188,828
Software [Member]
Total	82,899	78,996
Computers [Member]
Total	31,939
Leasehold Improvements [Member]
Total	696,325	697,333
Vehicles [Member]
Total	$ 183,589	$ 83,915

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	9 Months Ended		12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Sep. 30, 2019
Loan received from related party	$ 80,431	$ 144,193
Repayments of related party debt	71,063	$ 11,906
Keystone Labs [Member]
Loan received from related party	30,796		$ 191,515
Repayments of related party debt	19,248		9,034
Due to related party	355,070		354,050
Chief Operating Officer [Member]
Loan received from related party	40,014		194,820
Repayments of related party debt	0		1,040
Due to related party	$ 181,676		$ 143,780
Interest rate	0.00%		0.00%
Chief Executive Officer [Member]
Loan received from related party	$ 14,000		$ 75,000
Repayments of related party debt	5,750		19,200
Due to related party	$ 64,050		$ 55,800
Interest rate	0.00%		0.00%
Sara Lausmann [Member] | Oregon Analytical Services, LLC [Member]
Repayments of related party debt	$ 2,000		$ 0
Due to related party	$ 566,289		$ 568,299
Interest rate	5.00%		5.00%
Accrued interest	$ 122,095		$ 107,899
Anthony Smith [Member]
Repayments of related party debt	63,662		55,090
Due to related party	$ 117,247		$ 180,910
Interest rate	5.00%		5.00%
Accrued interest	$ 43,290		$ 41,600
Anthony Smith [Member] | Smith Scientific Industries, Inc. [Member]
Ownership percentage	80.00%		80.00%
Henry Grimmett [Member] | Greenhaus Analytical Services, LLC [Member] | Third Party [Member]
Notes payable	$ 170,000		$ 170,000
Henry Grimmett [Member] | Greenhaus Analytical Services, LLC [Member] | Interest 0% [Member]
Repayments of related party debt	0		3,859
Due to related party	$ 113,554		$ 113,554
Interest rate	0.00%		0.00%
Repayment of debt quarterly	$ 25,000		$ 25,000
Henry Grimmett [Member] | Greenhaus Analytical Services, LLC [Member] | Interest 6% [Member]
Due to related party	$ 0		$ 170,000
Interest rate	6.00%		6.00%
Accrued interest	$ 0		$ 59,412
Notes payable	$ 340,000		$ 340,000
Maturity date	Oct. 16, 2020		Oct. 16, 2020
Unamortized debt discount	$ 0		$ 25,563

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended	12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Mar. 31, 2020	Sep. 30, 2019
Common shares issued for services, value	$ 5,000	$ 10,807	$ 333,830	$ 331,151
Common shares issued for conversion of convertible debentures, value	$ 100,000		$ 1,619,385	$ 388,000
Common stock, shares issued	94,217,473			29,314,419
Common stock, shares outstanding	94,217,473			29,314,419
Common Stock [Member]
Conversion of stock, shares issued				532,500
Common shares issued for services				1,038,017
Common shares issued for services, value				$ 336,891
Common shares issued for cash				1,415,000
Common shares issued for cash, value				$ 586,000
Common shares issued for employee equity incentive plan				287,500
Common shares issued for employee equity incentive plan, value				$ 397,980
Common shares issued for conversion of convertible notes payable				2,054,887
Common shares issued for conversion of convertible notes payable, value				$ 687,200
Common shares issued for conversion of accrued interest				10,163
Common shares issued for conversion of accrued interest, value				$ 25,110
Common shares issued for conversion of convertible debentures				669,362
Common shares issued for conversion of convertible debentures, value				$ 388,000
Common Stock [Member] | Stock Purchase Agreement [Member]
Common shares issued for cash				20,000
Common shares issued for cash, value				$ 11,760
Common Stock [Member] | Accounts Payable [Member]
Common shares issued for settlement of debt				31,579
Common shares issued for settlement of debt, value				$ 15,000
Series A Convertible Preferred Stock [Member]
Preferred stock, shares issued	0			0
Preferred stock, shares outstanding	0			0
Series B Convertible Preferred Stock [Member]
Preferred stock, shares issued	5,000,000			5,000,000
Preferred stock, shares outstanding	5,000,000			5,000,000
Preferred stock, shares designated	5,000,000			5,000,000
Preferred stock, shares par value	$ 0.0001			$ 0.0001
Convertible preferred stock shares converted	1
Common shares issued for services
Common shares issued for services, value
Common shares issued for conversion of convertible debentures
Common shares issued for conversion of convertible debentures, value
Series C Convertible Preferred Stock [Member]
Preferred stock, shares issued	500,000			500,000
Preferred stock, shares outstanding	500,000			500,000
Preferred stock, shares designated	500,000			500,000
Preferred stock, shares par value	$ 0.0001			$ 0.0001
Convertible preferred stock shares converted	5
Common shares issued for services
Common shares issued for services, value
Common shares issued for conversion of convertible debentures
Common shares issued for conversion of convertible debentures, value
Series D Convertible Preferred Stock [Member]
Preferred stock, shares issued	349,500			349,500
Preferred stock, shares outstanding	349,500			349,500
Preferred stock, shares designated	1,000,000			1,000,000
Preferred stock, shares par value	$ 0.0001			$ 0.0001
Convertible preferred stock shares converted	2.5
Conversion of stock, shares converted				213,000
Common shares issued for services
Common shares issued for services, value
Common shares issued for conversion of convertible debentures
Common shares issued for conversion of convertible debentures, value

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Issuance of Common Shares (Details)	9 Months Ended
	Jun. 30, 2020USD ($)shares
Common Stock One [Member]
Number of Shares issued | shares	500,000
Description	Issuance of shares in exchange for consulting, professional and services
Value | $	$ 5,000
Common Stock Two [Member]
Number of Shares issued | shares	5,000,000
Description	Shares issued for acquisition of equity interests in subsidiaries
Value | $	$ 105,000
Common Stock Three [Member]
Number of Shares issued | shares	10,000,000
Description	Issuance of shares in connection with the conversion of debentures
Value | $	$ 100,000
Common Stock [Member]
Number of Shares issued | shares	15,500,000
Value | $	$ 210,000

Loans Payable (Details Narrativ

Loans Payable (Details Narrative) - USD ($)	Jun. 30, 2020	Sep. 30, 2019
Loans Payable [Member]
Accrued interest	$ 119,342	$ 74,301

Loans Payable - Schedule of Loa

Loans Payable - Schedule of Loans Payable (Details) - USD ($)	Jun. 30, 2020	Sep. 30, 2019
Total loans payable	$ 1,490,583	$ 1,420,079
Less: current portion of loans payable	788,006	762,476
Long-term portion of loans payable	702,578	657,603
Notes Payable 1 [Member]
Total loans payable	38,269	47,551
Notes Payable 2 [Member]
Total loans payable	603,470	622,523
Notes Payable 3 [Member]
Total loans payable	750,000	750,000
Notes Payable 4 [Member]
Total loans payable	$ 98,844

Loans Payable - Schedule of L_2

Loans Payable - Schedule of Loans Payable (Details) (Parenthetical) - USD ($)	Oct. 20, 2019	Jul. 05, 2018	Jun. 28, 2018	Mar. 16, 2018	Jul. 05, 2019
Notes Payable 1 [Member]
Debt instrument interest rate				6.637%
Debt instrument maturity date				Mar. 31, 2023
Notes Payable 2 [Member]
Debt instrument interest rate			8.00%
Debt instrument maturity date			Jun. 28, 2021
Debt instrument principal amount			$ 650,000
Notes Payable 3 [Member]
Debt instrument interest rate		8.00%
Debt instrument maturity date		Jan. 5, 2019
Debt instrument principal amount		$ 750,000
Penalty percentage					5.00%
Notes Payable 4 [Member]
Debt instrument interest rate	5.99%
Debt instrument maturity date	Dec. 31, 2023

Convertible Notes Payable (Deta

Convertible Notes Payable (Details Narrative)

Apr. 03, 2020USD ($)TradingDays

Feb. 04, 2020USD ($)TradingDays

Jan. 24, 2020USD ($)TradingDays

Jan. 21, 2020USD ($)TradingDays

Jan. 15, 2020USD ($)TradingDays

Jan. 03, 2020USD ($)TradingDays

Dec. 23, 2019USD ($)TradingDays

Nov. 04, 2019USD ($)TradingDays

Aug. 30, 2019USD ($)TradingDays

Aug. 29, 2019USD ($)TradingDays

Aug. 08, 2019USD ($)TradingDays

Jul. 05, 2019USD ($)

Jul. 02, 2019USD ($)TradingDays

Mar. 15, 2019USD ($)TradingDays

Feb. 11, 2019USD ($)TradingDays

Feb. 08, 2019USD ($)TradingDays

Feb. 05, 2019USD ($)TradingDays

Feb. 04, 2019USD ($)TradingDays

Dec. 27, 2018USD ($)TradingDays

Nov. 14, 2018USD ($)TradingDays$ / shares

Sep. 13, 2018USD ($)TradingDays

Sep. 06, 2018USD ($)TradingDays$ / shares

Aug. 01, 2018USD ($)TradingDays$ / shares

Jul. 02, 2018USD ($)$ / shares

Apr. 24, 2018USD ($)TradingDays$ / shares

Oct. 02, 2018USD ($)TradingDays$ / shares

Jun. 30, 2020USD ($)

Sep. 30, 2019USD ($)

Sep. 30, 2019USD ($)

Noteholder 1 [Member]

Debt instrument face amount

$ 500,000

$ 500,000

$ 500,000

$ 500,000

Percentage of asset exchange

100.00%

Debt instrument maturity date

Apr. 24, 2019

Apr. 24, 2019

Apr. 24, 2019

Debt conversion price per share | $ / shares

$ 1.25

Debt instrument trading price | $ / shares

$ 1.25

Debt instrument trading days | TradingDays

5

Debt instrument description

In the event the average lowest trading price of the Company's common stock during the five days prior to maturity is less than $1.25 per share, the Company will pay the noteholder the difference between $1.25 and the average lowest trading price during the preceding five days per share converted in cash. On or about April 30, 2020, Michele Malaret and Gordon Griswold filed, filed a breach of contract in the original principal amount of $500,000, with the Superior Court of California, County of Humboldt. The Company currently recognizes the full liability on its balance sheet. There is no interest due associated with the note.

Noteholder 2 [Member]

Debt instrument face amount

$ 220,000

Debt instrument maturity date

Oct. 1, 2018

Debt conversion price per share | $ / shares

$ 0.60

Debt instrument description

The note, together with accrued interest at the annual rate of 8%, was due on October 1, 2018. The principal amount of the note and any accrued interest thereon are convertible at the option of the holder into common shares of the Company at any time at a conversion price of $0.60 per share. This note was replaced on July 1, 2019.

Original issue discount

$ 20,000

Cash proceeds from convertible promissory note

$ 200,000

Debt instrument interest rate

8.00%

Noteholder 2 [Member]

Debt instrument face amount

$ 549,652

Debt instrument maturity date

Aug. 1, 2017

Debt instrument trading days | TradingDays

20

Debt instrument description

The new convertible note payable carries an interest rate of 0% per annum is convertible into common stock of the Company at the option of the noteholder immediately at 80% of the lowest volume-weighted average price of the Company's common stock in the preceding 20 trading days. This note was replaced on July 1, 2019.

Original issue discount

$ 35,348

Debt instrument interest rate

0.00%

Debt instrument threshold percentage

80.00%

Noteholder 2 [Member] | Palliatech [Member]

Debt instrument face amount

$ 585,000

Noteholder 2 [Member]

Debt instrument face amount

$ 825,890

$ 675,930

Debt instrument maturity date

Sep. 30, 2019

Debt instrument trading days | TradingDays

15

Debt instrument description

The note is convertible into common stock of the Company at the option of the noteholder at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days. There was $675,930 of principal and $61,154 of accrued interest on June 30, 2020.

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Default debt penalty, value

$ 150,000

Accrued interest

61,154

Noteholder 3 [Member]

Debt instrument face amount

$ 330,000

$ 396,000

$ 264,000

264,000

Debt instrument maturity date

Oct. 1, 2018

Jan. 1, 2019

Jan. 1, 2019

Debt conversion price per share | $ / shares

$ 0.50

Debt instrument trading days | TradingDays

15

Debt instrument description

The note, together with accrued interest at the annual rate of 8%, was due on October 1, 2018. The principal amount of the note and any accrued interest thereon are convertible at the option of the holder into common shares of the Company at any time the lower of a conversion price of $0.50 per share or at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Original issue discount

$ 30,000

Cash proceeds from convertible promissory note

$ 300,000

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Default debt penalty, value

$ 66,000

Accrued interest

$ 100,253

Noteholder 3 [Member]

Debt instrument face amount

$ 220,000

$ 264,000

Debt instrument maturity date

Jan. 1, 2019

Jan. 1, 2019

Debt conversion price per share | $ / shares

$ 0.50

Debt instrument trading days | TradingDays

15

Debt instrument description

The note, together with accrued interest at the annual rate of 8%, is due on January 1, 2019. The principal amount of the note and any accrued interest thereon are convertible at the option of the holder into common shares of the Company at any time at a conversion price of $0.50 per share or a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Original issue discount

$ 20,000

Cash proceeds from convertible promissory note

$ 200,000

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Default debt penalty, value

44,000

Accrued interest

$ 53,846

Noteholder 4 [Member]

Debt instrument face amount

$ 125,000

$ 145,000

145,000

Debt instrument maturity date

Sep. 6, 2019

Sep. 6, 2019

Debt conversion price per share | $ / shares

$ 0.50

Debt instrument trading days | TradingDays

15

Original issue discount

$ 15,000

Cash proceeds from convertible promissory note

$ 110,000

Debt instrument interest rate

10.00%

Debt instrument threshold percentage

35.00%

Default debt penalty, value

$ 20,000

Noteholder 5 [Member]

Debt instrument face amount

$ 62,500

$ 82,500

82,500

Debt instrument maturity date

Sep. 6, 2019

Sep. 17, 2019

Sep. 17, 2019

Debt conversion price per share | $ / shares

$ 0.50

Debt instrument trading days | TradingDays

15

Original issue discount

$ 6,250

Cash proceeds from convertible promissory note

$ 56,250

Debt instrument interest rate

10.00%

Debt instrument threshold percentage

35.00%

Default debt penalty, value

$ 20,000

Accrued interest

$ 10,260

Noteholder 6 [Member]

Debt instrument face amount

$ 222,600

$ 131,250

131,250

Debt instrument maturity date

Nov. 15, 2019

Nov. 15, 2019

Jan. 14, 2020

Debt conversion price per share | $ / shares

$ 0.50

Debt instrument trading days | TradingDays

15

Debt instrument description

The note, together with accrued interest at the annual rate of 8%, is due on November 15, 2019. The principal amount of the note and any accrued interest thereon are convertible at the option of the holder into common shares of the Company at any time at the lower of a conversion price of $0.50 per share or at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Original issue discount

$ 12,600

Cash proceeds from convertible promissory note

$ 210,000

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 15,564

Noteholder 6 [Member]

Debt instrument face amount

$ 265,000

$ 230,000

$ 265,000

265,000

Debt instrument maturity date

Feb. 4, 2020

Feb. 4, 2020

Feb. 4, 2020

Debt instrument trading days | TradingDays

15

Debt instrument description

The convertible note payable carries interest at a rate of 8% per annum, is due on February 4, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Original issue discount

$ 15,000

Cash proceeds from convertible promissory note

$ 240,000

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 26,938

Cash paid to third parties

$ 10,000

Noteholder 6 [Member]

Debt instrument face amount

$ 33,092

$ 33,092

$ 70,913

70,913

Debt instrument maturity date

Aug. 8, 2020

Aug. 8, 2020

Mar. 15, 2020

Debt instrument trading days | TradingDays

15

Debt instrument description

The convertible note payable carries interest at a rate of 8% per annum, is due on August 8, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Cash proceeds from convertible promissory note

$ 31,516

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 2,372

Cash paid to third parties

$ 1,576

Noteholder 6 [Member]

Debt instrument face amount

$ 33,516

$ 33,516

$ 33,092

33,092

Debt instrument maturity date

Nov. 4, 2020

Nov. 4, 2020

Aug. 8, 2020

Debt instrument trading days | TradingDays

15

Debt instrument description

The convertible note payable carries interest at a rate of 8% per annum, is due on November 4, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Cash proceeds from convertible promissory note

$ 31,516

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 1,756

Cash paid to third parties

$ 2,000

Noteholder 6 [Member]

Debt instrument face amount

$ 137,375

$ 137,375

Debt instrument maturity date

Dec. 23, 2020

Dec. 23, 2020

Debt instrument trading days | TradingDays

15

Debt instrument description

The convertible note payable carries interest at a rate of 8% per annum, is due on December 23, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Cash proceeds from convertible promissory note

$ 121,000

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 5,721

Cash paid to third parties

$ 16,375

Noteholder 6 [Member]

Debt instrument face amount

$ 52,500

$ 52,500

Debt instrument maturity date

Jan. 21, 2021

Feb. 21, 2021

Debt instrument trading days | TradingDays

15

Debt instrument description

The convertible note payable carries interest at a rate of 8% per annum, is due on January 21, 2021, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Cash proceeds from convertible promissory note

$ 50,000

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 2,532

Cash paid to third parties

$ 2,500

Noteholder 6 [Member]

Debt instrument face amount

$ 265,637

$ 265,637

Debt instrument maturity date

Feb. 8, 2020

Feb. 4, 2020

Debt instrument trading days | TradingDays

15

Debt instrument description

The new convertible note payable carries an interest rate of 8% per annum is due on February 8, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 14,774

Noteholder 7 [Member]

Debt instrument face amount

$ 105,000

$ 20,000

$ 131,250

131,250

Debt instrument maturity date

Dec. 27, 2019

Dec. 27, 2019

Feb. 5, 2020

Debt instrument trading days | TradingDays

15

Debt instrument description

The Note, together with accrued interest at the annual rate of 8%, is due on December 27, 2019, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 3,695

Noteholder 7 [Member]

Debt instrument face amount

$ 131,250

$ 131,250

$ 70,913

70,913

Debt instrument maturity date

Feb. 5, 2020

Feb. 5, 2020

Mar. 15, 2020

Debt instrument trading days | TradingDays

15

Debt instrument description

The convertible note payable carries interest at a rate of 8% per annum, is due on February 5, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Cash proceeds from convertible promissory note

$ 125,000

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 14,613

Cash paid to third parties

$ 6,250

Noteholder 7 [Member]

Debt instrument face amount

$ 131,250

$ 131,250

$ 33,092

33,092

Debt instrument maturity date

Jan. 14, 2020

Feb. 11, 2020

Aug. 8, 2020

Debt instrument trading days | TradingDays

15

Debt instrument description

The convertible note payable carries interest at a rate of 8% per annum, is due on January 14, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Cash proceeds from convertible promissory note

$ 125,000

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 14,325

Cash paid to third parties

$ 6,250

Noteholder 7 [Member]

Debt instrument face amount

$ 70,913

$ 70,913

Debt instrument maturity date

Mar. 15, 2020

Mar. 15, 2020

Debt instrument trading days | TradingDays

15

Debt instrument description

The new convertible note payable carries an interest rate of 8% per annum is due on March 15, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 7,352

Noteholder 7 [Member]

Debt instrument face amount

$ 33,092

$ 33,092

Debt instrument maturity date

Aug. 8, 2020

Aug. 8, 2020

Debt instrument trading days | TradingDays

15

Debt instrument description

The convertible note payable carries interest at a rate of 8% per annum, is due on August 8, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Cash proceeds from convertible promissory note

$ 31,516

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 2,372

Cash paid to third parties

$ 1,576

Noteholder 7 [Member]

Debt instrument face amount

$ 33,516

$ 33,516

Debt instrument maturity date

Nov. 4, 2020

Nov. 4, 2020

Debt instrument trading days | TradingDays

15

Debt instrument description

The convertible note payable carries interest at a rate of 8% per annum, is due on November 4, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Cash proceeds from convertible promissory note

$ 31,516

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 1,756

Cash paid to third parties

$ 2,000

Noteholder 7 [Member]

Debt instrument face amount

$ 137,375

$ 137,375

Debt instrument maturity date

Dec. 23, 2020

Jan. 3, 2021

Debt instrument trading days | TradingDays

15

Debt instrument description

The convertible note payable carries interest at a rate of 8% per annum, is due on December 23, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Cash proceeds from convertible promissory note

$ 121,000

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 5,480

Cash paid to third parties

$ 16,375

Noteholder 7 [Member]

Debt instrument face amount

$ 52,500

$ 52,500

Debt instrument maturity date

Jan. 21, 2021

Feb. 22, 2021

Debt instrument trading days | TradingDays

15

Debt instrument description

The convertible note payable carries interest at a rate of 8% per annum, is due on January 21, 2021, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Cash proceeds from convertible promissory note

$ 50,000

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 2,532

Cash paid to third parties

$ 2,500

Noteholder 7 [Member]

Debt instrument face amount

$ 265,637

$ 265,637

Debt instrument maturity date

Feb. 8, 2020

Feb. 4, 2020

Debt instrument trading days | TradingDays

15

Debt instrument description

The new convertible note payable carries an interest rate of 8% per annum is due on February 8, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 14,774

Noteholder 8 [Member]

Debt instrument face amount

$ 580,537

$ 783,724

783,724

Debt instrument maturity date

Feb. 8, 2020

Feb. 8, 2020

Debt instrument trading days | TradingDays

15

Debt instrument interest rate

10.00%

Debt instrument threshold percentage

30.00%

Default debt penalty, value

$ 203,188

Noteholder 9 [Member]

Debt instrument face amount

$ 70,913

$ 70,913

70,913

Debt instrument maturity date

Mar. 15, 2020

Mar. 15, 2020

Debt instrument trading days | TradingDays

15

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Noteholder 10 [Member]

Debt instrument face amount

$ 70,913

$ 70,913

$ 70,913

70,913

Debt instrument maturity date

Mar. 15, 2020

Mar. 15, 2020

Mar. 15, 2020

Debt instrument trading days | TradingDays

15

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 7,352

Noteholder 11 [Member]

Debt instrument face amount

$ 110,000

$ 110,000

$ 110,000

$ 110,000

Debt instrument maturity date

May 30, 2020

May 30, 2020

May 30, 2020

Debt instrument trading days | TradingDays

15

Debt instrument description

The convertible note payable carries interest at a rate of 8% per annum, is due on May 30, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Original issue discount

$ 10,000

Cash proceeds from convertible promissory note

$ 100,000

Debt instrument interest rate

8.00%

Debt instrument threshold percentage

35.00%

Accrued interest

$ 7,353

Noteholder 11 [Member]

Debt instrument face amount

$ 66,000

$ 170,000

$ 100,000

Debt instrument maturity date

Apr. 3, 2021

May 29, 2020

Apr. 3, 2021

Debt instrument trading days | TradingDays

15

15

Debt instrument description

The convertible note payable carries interest at a rate of 10% per annum, is due on April 3, 2021, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

The new convertible note payable carries an interest rate of 8% per annum, is due on May 29, 2020, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 35% discount from the lowest trading price of the Company's common stock in the preceding 15 trading days.

Original issue discount

$ 6,000

Cash proceeds from convertible promissory note

$ 60,000

Debt instrument interest rate

10.00%

8.00%

Debt instrument threshold percentage

35.00%

35.00%

Accrued interest

$ 0

Noteholder 11 [Member]

Debt instrument face amount

$ 66,000

Accrued interest

$ 1,591

Noteholder 12 [Member]

Debt instrument face amount

$ 100,000

$ 100,000

Debt instrument maturity date

Apr. 14, 2021

Debt instrument interest rate

0.00%

Noteholder 12 [Member]

Debt instrument maturity date

Jan. 23, 2021

Debt instrument trading days | TradingDays

5

Debt instrument description

The convertible note payable carries interest at a rate of 0% per annum, is due on January 23, 2021, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 20% discount from the lowest trading price of the Company's common stock in the preceding 5 trading days.

Debt instrument threshold percentage

20.00%

Noteholder 12 [Member]

Debt instrument face amount

$ 100,000

Accrued interest

$ 1,372

Noteholder 13 [Member]

Debt instrument face amount

$ 50,000

$ 50,000

Debt instrument maturity date

Jan. 23, 2021

Debt instrument interest rate

0.00%

Noteholder 13 [Member]

Debt instrument maturity date

Jan. 23, 2021

Debt instrument trading days | TradingDays

5

Debt instrument description

The convertible note payable carries interest at a rate of 0% per annum, is due on January 23, 2021, and is convertible into common stock of the Company at the option of the noteholder six months after issuance at a rate equal to a 20% discount from the lowest trading price of the Company's common stock in the preceding 5 trading days.

Debt instrument threshold percentage

20.00%

Noteholder 13 [Member]

Debt instrument face amount

$ 50,000

Accrued interest

$ 0

Convertible Notes Payable - Sch

Convertible Notes Payable - Schedule of Convertible Notes Payable (Details) - USD ($)

Apr. 03, 2020

Feb. 04, 2020

Jan. 21, 2020

Jan. 03, 2020

Dec. 23, 2019

Nov. 04, 2019

Aug. 30, 2019

Aug. 29, 2019

Aug. 08, 2019

Mar. 15, 2019

Feb. 11, 2019

Feb. 08, 2019

Feb. 05, 2019

Feb. 04, 2019

Dec. 27, 2018

Nov. 15, 2018

Nov. 14, 2018

Sep. 06, 2018

Aug. 01, 2018

Apr. 24, 2018

Oct. 02, 2018

Jun. 30, 2020

Sep. 30, 2019

Jan. 24, 2020

Jan. 15, 2020

Accrued interest

$ 1,693,136

$ 1,387,642

Noteholder 1 [Member]

Issue date

Apr. 24, 2018

Apr. 24, 2018

Due date

Apr. 24, 2019

Apr. 24, 2019

Apr. 24, 2019

Principal

$ 500,000

$ 500,000

$ 500,000

Unamortized debt discount

Carrying value

500,000

500,000

Accrued interest

Noteholder 2 [Member]

Issue date

Jul. 1, 2019

Jul. 1, 2019

Due date

Sep. 30, 2019

Sep. 30, 2019

Principal

$ 675,930

$ 825,930

Unamortized debt discount

Carrying value

675,930

825,930

Accrued interest

$ 61,154

$ 18,983

Noteholder 3 [Member]

Issue date

Aug. 1, 2018

Oct. 2, 2018

Due date

Oct. 1, 2018

Jan. 1, 2019

Jan. 1, 2019

Principal

$ 330,000

$ 396,000

$ 264,000

Unamortized debt discount

Carrying value

396,000

264,000

Accrued interest

$ 100,253

$ 40,634

Noteholder 3 [Member]

Issue date

Oct. 2, 2018

Due date

Jan. 1, 2019

Jan. 1, 2019

Principal

$ 220,000

$ 264,000

Unamortized debt discount

Carrying value

264,000

Accrued interest

$ 53,846

Noteholder 5 [Member]

Issue date

Sep. 17, 2018

Sep. 17, 2018

Due date

Sep. 6, 2019

Sep. 17, 2019

Sep. 17, 2019

Principal

$ 62,500

$ 82,500

Unamortized debt discount

Carrying value

82,500

Accrued interest

$ 10,260

$ 8,586

Noteholder 6 [Member]

Issue date

Nov. 15, 2018

Jan. 14, 2019

Due date

Nov. 15, 2019

Nov. 15, 2019

Jan. 14, 2020

Principal

$ 222,600

$ 131,250

Unamortized debt discount

(46,027)

Carrying value

85,223

Accrued interest

$ 15,564

$ 7,364

Noteholder 6 [Member]

Issue date

Feb. 4, 2019

Feb. 4, 2019

Due date

Feb. 4, 2020

Feb. 4, 2020

Feb. 4, 2020

Principal

$ 265,000

$ 230,000

$ 265,000

Unamortized debt discount

(92,205)

Carrying value

230,000

172,795

Accrued interest

$ 26,938

$ 13,824

Noteholder 6 [Member]

Issue date

Aug. 8, 2019

Mar. 15, 2019

Due date

Aug. 8, 2020

Aug. 8, 2020

Mar. 15, 2020

Principal

$ 33,092

$ 33,092

$ 70,913

Unamortized debt discount

(1,282)

Carrying value

31,810

70,913

Accrued interest

$ 2,372

$ 3,093

Noteholder 6 [Member]

Issue date

Nov. 4, 2019

Aug. 8, 2019

Due date

Nov. 4, 2020

Nov. 4, 2020

Aug. 8, 2020

Principal

$ 33,516

$ 33,516

$ 33,092

Unamortized debt discount

(11,630)

(10,291)

Carrying value

21,886

22,801

Accrued interest

$ 1,756

$ 384

Noteholder 6 [Member]

Issue date

Dec. 23, 2019

Due date

Dec. 23, 2020

Dec. 23, 2020

Principal

$ 137,375

$ 137,375

Unamortized debt discount

(66,060)

Carrying value

71,315

Accrued interest

$ 5,721

Noteholder 6 [Member]

Issue date

Jan. 21, 2020

Due date

Jan. 21, 2021

Feb. 21, 2021

Principal

$ 52,500

$ 52,500

Unamortized debt discount

(2,500)

Carrying value

50,000

Accrued interest

$ 2,532

Noteholder 6 [Member]

Issue date

Feb. 4, 2020

Due date

Feb. 8, 2020

Feb. 4, 2020

Principal

$ 265,637

$ 265,637

Unamortized debt discount

Carrying value

265,637

Accrued interest

$ 14,774

Noteholder 7 [Member]

Issue date

Dec. 27, 2018

Feb. 5, 2019

Due date

Dec. 27, 2019

Dec. 27, 2019

Feb. 5, 2020

Principal

$ 105,000

$ 20,000

$ 131,250

Unamortized debt discount

(48,185)

Carrying value

20,000

83,065

Accrued interest

$ 3,695

$ 6,616

Noteholder 7 [Member]

Issue date

Feb. 5, 2019

Mar. 15, 2019

Due date

Feb. 5, 2020

Feb. 5, 2020

Mar. 15, 2020

Principal

$ 131,250

$ 131,250

$ 70,913

Unamortized debt discount

Carrying value

131,250

70,913

Accrued interest

$ 14,613

$ 3,093

Noteholder 7 [Member]

Issue date

Feb. 11, 2019

Aug. 8, 2019

Due date

Jan. 14, 2020

Feb. 11, 2020

Aug. 8, 2020

Principal

$ 131,250

$ 131,250

$ 33,092

Unamortized debt discount

(10,291)

Carrying value

131,250

22,801

Accrued interest

$ 14,325

$ 384

Noteholder 7 [Member]

Issue date

Mar. 15, 2019

Due date

Mar. 15, 2020

Mar. 15, 2020

Principal

$ 70,913

$ 70,913

Unamortized debt discount

Carrying value

70,913

Accrued interest

$ 7,352

Noteholder 7 [Member]

Issue date

Aug. 8, 2019

Due date

Aug. 8, 2020

Aug. 8, 2020

Principal

$ 33,092

$ 33,092

Unamortized debt discount

(1,282)

Carrying value

31,810

Accrued interest

$ 2,372

Noteholder 7 [Member]

Issue date

Nov. 4, 2019

Due date

Nov. 4, 2020

Nov. 4, 2020

Principal

$ 33,516

$ 33,516

Unamortized debt discount

(11,630)

Carrying value

21,886

Accrued interest

$ 1,756

Noteholder 7 [Member]

Issue date

Jan. 3, 2020

Due date

Dec. 23, 2020

Jan. 3, 2021

Principal

$ 137,375

$ 137,375

Unamortized debt discount

Carrying value

137,375

Accrued interest

$ 5,480

Noteholder 7 [Member]

Issue date

Jan. 21, 2020

Due date

Jan. 21, 2021

Feb. 22, 2021

Principal

$ 52,500

$ 52,500

Unamortized debt discount

(2,500)

Carrying value

50,000

Accrued interest

$ 2,532

Noteholder 7 [Member]

Issue date

Feb. 4, 2020

Due date

Feb. 8, 2020

Feb. 4, 2020

Principal

$ 265,637

$ 265,637

Unamortized debt discount

Carrying value

265,637

Accrued interest

$ 14,774

Noteholder 10 [Member]

Issue date

Mar. 15, 2019

Mar. 15, 2019

Due date

Mar. 15, 2020

Mar. 15, 2020

Mar. 15, 2020

Principal

$ 70,913

$ 70,913

$ 70,913

Unamortized debt discount

Carrying value

70,913

70,913

Accrued interest

$ 7,352

$ 3,093

Noteholder 11 [Member]

Issue date

Aug. 30, 2019

Aug. 30, 2019

Due date

May 30, 2020

May 30, 2020

May 30, 2020

Principal

$ 110,000

$ 110,000

$ 110,000

Unamortized debt discount

(97,555)

Carrying value

110,000

12,445

Accrued interest

$ 7,353

747

Noteholder 11 [Member]

Issue date

Apr. 30, 2020

Due date

Apr. 3, 2021

May 29, 2020

Apr. 3, 2021

Principal

$ 66,000

$ 170,000

$ 100,000

Unamortized debt discount

(41,900)

Carrying value

24,100

Accrued interest

$ 1,591

Noteholder 12 [Member]

Issue date

Jan. 15, 2020

Due date

Apr. 14, 2021

Principal

$ 100,000

$ 100,000

Unamortized debt discount

0

Carrying value

100,000

Accrued interest

$ 1,372

Noteholder 13 [Member]

Issue date

Jan. 24, 2020

Due date

Jan. 23, 2021

Principal

$ 50,000

$ 50,000

Unamortized debt discount

Carrying value

50,000

Accrued interest

Noteholder [Member]

Principal

3,860,496

4,412,090

Unamortized debt discount

(138,784)

(716,714)

Carrying value

3,721,712

3,695,376

Accrued interest

$ 379,737

$ 326,145

Noteholder 3 [Member]

Issue date

Aug. 1, 2018

Due date

Jan. 1, 2019

Principal

$ 396,000

Unamortized debt discount

Carrying value

396,000

Accrued interest

$ 76,471

Noteholder 4 [Member]

Issue date

Sep. 6, 2018

Due date

Sep. 6, 2019

Sep. 6, 2019

Principal

$ 125,000

$ 145,000

Unamortized debt discount

Carrying value

145,000

Accrued interest

$ 15,575

Noteholder 6 [Member]

Issue date

Nov. 15, 2018

Due date

Nov. 15, 2019

Nov. 15, 2019

Principal

$ 222,600

$ 222,600

Unamortized debt discount

$ (184,957)

(28,054)

Carrying value

194,546

Accrued interest

$ 15,564

Noteholder 7 [Member]

Issue date

Dec. 27, 2018

Due date

Dec. 27, 2019

Dec. 27, 2019

Principal

$ 105,000

$ 105,000

Unamortized debt discount

$ (38,365)

(25,603)

Carrying value

79,397

Accrued interest

$ 18,204

Noteholder 8 [Member]

Issue date

Feb. 8, 2019

Due date

Feb. 8, 2020

Feb. 8, 2020

Principal

$ 580,537

$ 783,724

Unamortized debt discount

(208,357)

Carrying value

575,367

Accrued interest

$ 89,627

Noteholder 9 [Member]

Issue date

Mar. 15, 2019

Due date

Mar. 15, 2020

Mar. 15, 2020

Principal

$ 70,913

$ 70,913

Unamortized debt discount

Carrying value

70,913

Accrued interest

$ 3,093

Noteholder 11 [Member]

Issue date

Aug. 29, 2019

Due date

May 29, 2020

Principal

$ 100,000

Unamortized debt discount

(150,146)

Carrying value

(50,146)

Accrued interest

$ 964

Convertible Debentures (Details

Convertible Debentures (Details Narrative) - USD ($)	Jan. 29, 2018	Jun. 30, 2020	Jun. 30, 2019
Proceeds from convertible debt		$ 1,055,102	$ 1,078,732
8% Unsecured Convertible Debentures [Member]
Issuance of debentures	5,973
Debt instrument interest rate	8.00%
Debt instrument principal amount	$ 1,000
Number of warrants to issued	250
Proceeds from convertible debt	$ 5,973,000
Warrants exercise price	$ 0.80
Warrant term	24 months
Debt instrument term	36 months
Debt conversion price per share	$ 0.60
Convertible Debentures [Member]
Debt instrument interest rate	6.00%
Number of warrants to issued	597,300
Warrants exercise price	$ 0.60
Warrant term	2 years
Three Separate Debentures [Member]
Number of warrants to issued		152,500
Proceeds from convertible debt		$ 610,000
Warrants exercise price		$ 0.80
Debt conversion price per share		$ 0.60

Derivative Liability (Details N

Derivative Liability (Details Narrative)

Apr. 03, 2020USD ($)

Dec. 23, 2019USD ($)

Nov. 04, 2019USD ($)

Aug. 30, 2019USD ($)

Aug. 29, 2019USD ($)

Aug. 08, 2019USD ($)

Jul. 02, 2019USD ($)

Feb. 05, 2019USD ($)

Feb. 04, 2019USD ($)

Jan. 14, 2019USD ($)

Dec. 27, 2018USD ($)

Nov. 15, 2018USD ($)

Oct. 02, 2018USD ($)shares

Jun. 30, 2020USD ($)shares

Aug. 08, 2020USD ($)

Sep. 30, 2019USD ($)

Derivative liability

$ 2,134,395

$ 2,545,735

Unrealized gain on derivative liability

411,340

411,340

Unrealized loss on derivative liability

556,647

556,647

Conversion Features [Member]

Derivative liability

2,134,395

Unrealized gain on derivative liability

$ 332,993

Conversion Features [Member] | Measurement Input, Price Volatility [Member]

Derivative liability measurement input

168

Conversion Features [Member] | Measurement Input, Risk Free Interest Rate [Member]

Derivative liability measurement input

0.16

Conversion Features [Member] | Measurement Input, Exercise Price [Member] | Minimum [Member]

Derivative liability measurement input

0.011

Conversion Features [Member] | Measurement Input, Exercise Price [Member] | Maximum [Member]

Derivative liability measurement input

0.019

Conversion Features [Member] | Measurement Input, Expected Term [Member] | Minimum [Member]

Derivative liability measurement input term

1 month 9 days

Conversion Features [Member] | Measurement Input, Expected Term [Member] | Maximum [Member]

Derivative liability measurement input term

6 months

Warrants [Member]

Derivative liability

$ 57,014

Debt instrument discount

$ 53,333

Loss on derivative fair value measurement

3,681

Number of warrants to issued | shares

100,000

Warrants [Member] | October 17, 2020 to October 23, 2020 [Member]

Derivative liability

$ 73,383

Number of warrants to issued | shares

187,000

Warrants [Member] | Measurement Input, Price Volatility [Member]

Derivative liability measurement input

168

Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member]

Derivative liability measurement input

0.16

Warrants [Member] | Measurement Input, Exercise Price [Member] | Minimum [Member]

Derivative liability measurement input

0.60

Warrants [Member] | Measurement Input, Exercise Price [Member] | Maximum [Member]

Derivative liability measurement input

0.80

Warrants [Member] | Measurement Input, Expected Term [Member] | Minimum [Member]

Derivative liability measurement input term

3 months 4 days

Warrants [Member] | Measurement Input, Expected Term [Member] | Maximum [Member]

Derivative liability measurement input term

3 months 19 days

Convertible Debenture [Member]

Debt instrument face amount

$ 220,000

Debt instrument maturity date

Jan. 1, 2019

Convertible Debenture [Member] | October 17, 2020 to October 23, 2020 [Member]

Debt instrument face amount

$ 374,000

Fair value of derivatives

$ 44

Noteholder 6 [Member]

Derivative liability

$ 220,463

Debt instrument face amount

$ 222,600

$ 222,600

Debt instrument maturity date

Nov. 15, 2019

Nov. 15, 2019

Debt instrument discount

$ 184,957

$ 28,054

Loss on derivative fair value measurement

$ 35,506

Noteholder 6 [Member] | Convertible Promissory Note [Member]

Derivative liability

$ 204,554

$ 33,516

$ 34,341

Debt instrument face amount

$ 137,375

$ 33,516

$ 33,092

Debt instrument maturity date

Dec. 23, 2020

Nov. 4, 2020

Aug. 8, 2020

Loss on derivative fair value measurement

$ 204,554

$ 17,021

$ 34,341

Noteholder 7 [Member]

Derivative liability

$ 98,091

Debt instrument face amount

$ 105,000

$ 105,000

Debt instrument maturity date

Dec. 27, 2019

Dec. 27, 2019

Debt instrument discount

$ 38,365

$ 25,603

Loss on derivative fair value measurement

$ 59,725

Noteholder 7 [Member] | Convertible Promissory Note [Member]

Derivative liability

33,516

34,341

Debt instrument face amount

$ 33,516

$ 33,092

Debt instrument maturity date

Nov. 4, 2020

Aug. 8, 2020

Loss on derivative fair value measurement

$ 17,021

$ 34,341

Noteholder 8 [Member]

Derivative liability

$ 144,752

Debt instrument face amount

$ 131,250

Debt instrument maturity date

Feb. 5, 2020

Debt instrument discount

$ 14,423

Loss on derivative fair value measurement

$ 130,329

Noteholder 8 [Member]

Derivative liability

$ 322,521

Debt instrument face amount

$ 265,000

Debt instrument maturity date

Feb. 4, 2020

Loss on derivative fair value measurement

$ 322,521

Noteholder 9 [Member]

Derivative liability

$ 228,916

Debt instrument face amount

$ 131,250

Debt instrument maturity date

Feb. 11, 2020

Loss on derivative fair value measurement

$ 228,916

Noteholder 3 [Member]

Debt instrument face amount

$ 396,000

Debt instrument maturity date

Jan. 1, 2019

Debt instrument discount

Noteholder 3 [Member] | Convertible Promissory Note [Member]

Derivative liability

$ 1,807,875

Debt instrument face amount

$ 825,930

Debt instrument maturity date

Sep. 30, 2019

Loss on derivative fair value measurement

$ 1,807,875

Noteholder 14 [Member] | Convertible Promissory Note [Member]

Derivative liability

$ 143,951

Debt instrument face amount

$ 170,000

Debt instrument maturity date

May 29, 2020

Loss on derivative fair value measurement

$ 65,965

Noteholder 14 [Member] | Convertible Promissory Note [Member]

Derivative liability

$ 109,936

Debt instrument face amount

$ 110,000

Debt instrument maturity date

May 30, 2020

Loss on derivative fair value measurement

$ 79,183

Noteholder 11 [Member]

Debt instrument face amount

$ 100,000

Debt instrument maturity date

May 29, 2020

Debt instrument discount

$ 150,146

Noteholder 11 [Member] | Convertible Promissory Note [Member]

Derivative liability

$ 78,115

Debt instrument face amount

$ 66,000

Debt instrument maturity date

Nov. 30, 2020

Loss on derivative fair value measurement

$ 6,796

Derivative Liability - Schedule

Derivative Liability - Schedule of Derivative Liabilities (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Derivative Liability [Abstract]
Balance, September 30, 2019			$ 2,545,735
Change in fair market value	$ (224,783)	$ (981,421)	(450,580)	$ (424,774)
Balance, June 30, 2020	$ 2,134,395		$ 2,134,395

Derivative Liability - Summary

Derivative Liability - Summary of Gain (Loss) on Derivative Liability (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Derivative Liability [Abstract]
Day one loss due to derivatives on convertible debt			$ (414,478)	$ (780,678)
Change in fair value of derivatives			825,818	1,225,743
Total derivative gain (loss)	$ 224,783	$ 981,421	$ 450,580	$ 424,774

Stock Options and Warrants (Det

Stock Options and Warrants (Details Narrative) - USD ($)	9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Stock Options And Warrants
Stock option expense	$ 126,581	$ 169,922

Stock Options and Warrants - Su

Stock Options and Warrants - Summary of Stock Option and Warrant Activity (Details)	9 Months Ended
	Jun. 30, 2020$ / sharesshares
Stock Options And Warrants
Beginning balance, Shares | shares	5,484,970
Granted, Shares | shares
Exercised, Shares | shares
Forfeited, Shares | shares
Expired, Shares | shares
Ending balance, Shares | shares	5,484,970
Weighted-Average Exercise Price Per Share, Beginning balance | $ / shares	$ 0.742
Weighted-Average Exercise Price Per Share, Granted | $ / shares
Weighted-Average Exercise Price Per Share, Exercised | $ / shares
Weighted-Average Exercise Price Per Share, Forfeited | $ / shares
Weighted-Average Exercise Price Per Share, Expired | $ / shares
Weighted-Average Exercise Price Per Share, Ending balance | $ / shares	$ 0.742

Stock Options and Warrants - Sc

Stock Options and Warrants - Schedule of Outstanding and Exercisable Options and Warrants (Details)	9 Months Ended
	Jun. 30, 2020$ / sharesshares
Number of Option Shares, Outstanding | shares	5,484,970
Weighted Average Exercise Price, Outstanding | $ / shares	$ 0.742
Weighted Average Remaining Life (Years), Outstanding	1 year 11 months 12 days
Number of Option Shares, Exercisable | shares	4,713,720
Weighted Average Exercise Price, Exercisable | $ / shares	$ 0.718
Exercise Prices One [Member]
Number of Option Shares, Outstanding | shares	200,000
Weighted Average Exercise Price, Outstanding | $ / shares	$ 0.225
Weighted Average Remaining Life (Years), Outstanding	4 years 5 months 16 days
Number of Option Shares, Exercisable | shares	200,000
Weighted Average Exercise Price, Exercisable | $ / shares	$ 0.225
Exercise Prices Two [Member]
Number of Option Shares, Outstanding | shares	110,000
Weighted Average Exercise Price, Outstanding | $ / shares	$ 0.400
Weighted Average Remaining Life (Years), Outstanding	1 year 7 months 13 days
Number of Option Shares, Exercisable | shares	110,000
Weighted Average Exercise Price, Exercisable | $ / shares	$ 0.400
Exercise Prices Three [Member]
Number of Option Shares, Outstanding | shares	330,000
Weighted Average Exercise Price, Outstanding | $ / shares	$ 0.420
Weighted Average Remaining Life (Years), Outstanding	4 years 18 days
Number of Option Shares, Exercisable | shares	330,000
Weighted Average Exercise Price, Exercisable | $ / shares	$ 0.420
Exercise Prices Four [Member]
Number of Option Shares, Outstanding | shares	165,000
Weighted Average Exercise Price, Outstanding | $ / shares	$ 0.500
Weighted Average Remaining Life (Years), Outstanding	1 year 8 months 12 days
Number of Option Shares, Exercisable | shares	162,500
Weighted Average Exercise Price, Exercisable | $ / shares	$ 0.500
Exercise Prices Five [Member]
Number of Option Shares, Outstanding | shares	627,220
Weighted Average Exercise Price, Outstanding | $ / shares	$ 0.600
Weighted Average Remaining Life (Years), Outstanding	1 month 9 days
Number of Option Shares, Exercisable | shares	627,220
Weighted Average Exercise Price, Exercisable | $ / shares	$ 0.600
Exercise Prices Six [Member]
Number of Option Shares, Outstanding | shares	145,000
Weighted Average Exercise Price, Outstanding | $ / shares	$ 0.650
Weighted Average Remaining Life (Years), Outstanding	2 years 9 months 25 days
Number of Option Shares, Exercisable | shares	36,250
Weighted Average Exercise Price, Exercisable | $ / shares	$ 0.650
Exercise Prices Seven [Member]
Number of Option Shares, Outstanding | shares	3,482,750
Weighted Average Exercise Price, Outstanding | $ / shares	$ 0.800
Weighted Average Remaining Life (Years), Outstanding	1 year 5 months 5 days
Number of Option Shares, Exercisable | shares	3,095,250
Weighted Average Exercise Price, Exercisable | $ / shares	$ 0.800
Exercise Prices Eight [Member]
Number of Option Shares, Outstanding | shares	100,000
Weighted Average Exercise Price, Outstanding | $ / shares	$ 0.850
Weighted Average Remaining Life (Years), Outstanding	3 years 3 months 15 days
Number of Option Shares, Exercisable | shares
Weighted Average Exercise Price, Exercisable | $ / shares	$ 0.850
Exercise Prices Nine [Member]
Number of Option Shares, Outstanding | shares	25,000
Weighted Average Exercise Price, Outstanding | $ / shares	$ 1.050
Weighted Average Remaining Life (Years), Outstanding	3 years 9 months 14 days
Number of Option Shares, Exercisable | shares
Weighted Average Exercise Price, Exercisable | $ / shares	$ 1.050
Exercise Prices Ten [Member]
Number of Option Shares, Outstanding | shares	220,000
Weighted Average Exercise Price, Outstanding | $ / shares	$ 1.260
Weighted Average Remaining Life (Years), Outstanding	2 years 6 months
Number of Option Shares, Exercisable | shares	110,000
Weighted Average Exercise Price, Exercisable | $ / shares	$ 1.260
Exercise Prices Eleven [Member]
Number of Option Shares, Outstanding | shares	10,000
Weighted Average Exercise Price, Outstanding | $ / shares	$ 1.300
Weighted Average Remaining Life (Years), Outstanding	1 year 9 months 18 days
Number of Option Shares, Exercisable | shares	7,500
Weighted Average Exercise Price, Exercisable | $ / shares	$ 1.300
Exercise Price Twelve [Member]
Number of Option Shares, Outstanding | shares	60,000
Weighted Average Exercise Price, Outstanding | $ / shares	$ 1.386
Weighted Average Remaining Life (Years), Outstanding	2 years 6 months
Number of Option Shares, Exercisable | shares	30,000
Weighted Average Exercise Price, Exercisable | $ / shares	$ 1.386
Exercise Price Thirteen [Member]
Number of Option Shares, Outstanding | shares	10,000
Weighted Average Exercise Price, Outstanding | $ / shares	$ 1.666
Weighted Average Remaining Life (Years), Outstanding	2 years 7 months 2 days
Number of Option Shares, Exercisable | shares	5,000
Weighted Average Exercise Price, Exercisable | $ / shares	$ 1.666

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Apr. 30, 2020	Mar. 05, 2020
Paul Tomaso and Jonah Barber [Member] | MRX Labs, LLC [Member]
Debt instrument face amount		$ 750,000
Michele Malaret and Gordon Griswold [Member]
Debt instrument face amount	$ 500,000